GOName,GOID,DiseaseName,DiseaseID,InferenceChemicalQty,InferenceChemicalNames,InferenceGeneQty,InferenceGeneSymbols
3'-UTR-mediated mRNA stabilization,GO:0070935,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,TIRAP
3'-UTR-mediated mRNA stabilization,GO:0070935,Tuberculosis,MESH:D014376,0,,1,TIRAP
4-hydroxyproline metabolic process,GO:0019471,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
4-hydroxyproline metabolic process,GO:0019471,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
5-methylcytosine metabolic process,GO:0019857,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
5-methylcytosine metabolic process,GO:0019857,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
acetylcholine biosynthetic process,GO:0008292,Tuberculosis,MESH:D014376,1,Tretinoin,0,
acetylcholine metabolic process,GO:0008291,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
acetylcholine secretion,GO:0061526,Tuberculosis,MESH:D014376,1,Tretinoin,0,
actin cytoskeleton organization,GO:0030036,Paratuberculosis,MESH:D010283,0,,1,GSN
actin cytoskeleton organization,GO:0030036,Tuberculosis,MESH:D014376,0,,1,CORO1A
actin filament capping,GO:0051693,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
actin filament capping,GO:0051693,Paratuberculosis,MESH:D010283,0,,1,GSN
actin filament capping,GO:0051693,Tuberculosis,MESH:D014376,1,Isoniazid,0,
actin filament capping,GO:0051693,"Tuberculosis, Central Nervous System",MESH:D020306,1,Isoniazid,0,
actin filament capping,GO:0051693,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Isoniazid,0,
actin filament capping,GO:0051693,"Tuberculosis, Lymph Node",MESH:D014388,1,Isoniazid,0,
actin filament capping,GO:0051693,"Tuberculosis, Meningeal",MESH:D014390,1,Isoniazid,0,
actin filament capping,GO:0051693,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Isoniazid,0,
actin filament capping,GO:0051693,"Tuberculosis, Pleural",MESH:D014396,1,Isoniazid,0,
actin filament capping,GO:0051693,"Tuberculosis, Pulmonary",MESH:D014397,1,Isoniazid,0,
actin filament capping,GO:0051693,"Tuberculosis, Spinal",MESH:D014399,1,Isoniazid,0,
actin filament depolymerization,GO:0030042,Paratuberculosis,MESH:D010283,0,,1,GSN
actin filament organization,GO:0007015,Paratuberculosis,MESH:D010283,0,,2,GSN|TF
actin filament organization,GO:0007015,Tuberculosis,MESH:D014376,0,,1,CORO1A
actin filament polymerization,GO:0030041,Paratuberculosis,MESH:D010283,0,,1,GSN
actin filament reorganization,GO:0090527,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
actin filament reorganization,GO:0090527,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
actin filament severing,GO:0051014,Paratuberculosis,MESH:D010283,0,,1,GSN
actin polymerization or depolymerization,GO:0008154,Paratuberculosis,MESH:D010283,0,,1,GSN
action potential,GO:0001508,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
action potential,GO:0001508,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
activated T cell proliferation,GO:0050798,"Tuberculosis, Bovine",MESH:D014380,0,,1,IL4
activation of cysteine-type endopeptidase activity,GO:0097202,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
activation of cysteine-type endopeptidase activity,GO:0097202,Tuberculosis,MESH:D014376,1,Verapamil,0,
activation of cysteine-type endopeptidase activity,GO:0097202,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006919,Tuberculosis,MESH:D014376,1,Tretinoin,0,
activation of immune response,GO:0002253,Extensively Drug-Resistant Tuberculosis,MESH:D054908,1,Ethambutol,0,
activation of immune response,GO:0002253,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
activation of immune response,GO:0002253,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,TLR2
activation of immune response,GO:0002253,Tuberculosis,MESH:D014376,4,Ethambutol|Isoniazid|Pyrazinamide|Rifampin,0,
activation of immune response,GO:0002253,"Tuberculosis, Central Nervous System",MESH:D020306,4,Ethambutol|Isoniazid|Pyrazinamide|Rifampin,0,
activation of immune response,GO:0002253,"Tuberculosis, Gastrointestinal",MESH:D014385,2,Isoniazid|Rifampin,0,
activation of immune response,GO:0002253,"Tuberculosis, Lymph Node",MESH:D014388,4,Ethambutol|Isoniazid|Pyrazinamide|Rifampin,0,
activation of immune response,GO:0002253,"Tuberculosis, Meningeal",MESH:D014390,3,Isoniazid|Pyrazinamide|Rifampin,0,
activation of immune response,GO:0002253,"Tuberculosis, Miliary",MESH:D014391,1,Ethambutol,0,
activation of immune response,GO:0002253,"Tuberculosis, Multidrug-Resistant",MESH:D018088,4,Ethambutol|Isoniazid|Pyrazinamide|Rifampin,0,
activation of immune response,GO:0002253,"Tuberculosis, Osteoarticular",MESH:D014394,1,Ethambutol,0,
activation of immune response,GO:0002253,"Tuberculosis, Pleural",MESH:D014396,3,Ethambutol|Isoniazid|Rifampin,0,
activation of immune response,GO:0002253,"Tuberculosis, Pulmonary",MESH:D014397,4,Ethambutol|Isoniazid|Pyrazinamide|Rifampin,0,
activation of immune response,GO:0002253,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
activation of immune response,GO:0002253,"Tuberculosis, Spinal",MESH:D014399,4,Ethambutol|Isoniazid|Pyrazinamide|Rifampin,0,
activation of Janus kinase activity,GO:0042976,"Tuberculosis, Bovine",MESH:D014380,0,,1,IL4
activation of meiosis,GO:0090427,Tuberculosis,MESH:D014376,1,Tretinoin,0,
activation of protein kinase A activity,GO:0034199,Tuberculosis,MESH:D014376,1,Chenodeoxycholic Acid,0,
activation of protein kinase activity,GO:0032147,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,SLC11A1
activation of protein kinase activity,GO:0032147,Tuberculosis,MESH:D014376,0,,1,SLC11A1
activation of protein kinase B activity,GO:0032148,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
activation of protein kinase B activity,GO:0032148,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
acute inflammatory response,GO:0002526,Tuberculosis,MESH:D014376,0,,1,HP
acute inflammatory response to antigenic stimulus,GO:0002438,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
acute inflammatory response to antigenic stimulus,GO:0002438,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
acute-phase response,GO:0006953,Paratuberculosis,MESH:D010283,0,,2,F2|TF
acute-phase response,GO:0006953,Tuberculosis,MESH:D014376,0,,1,HP
adaptive immune response,GO:0002250,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,2,CD209|IFNG
adaptive immune response,GO:0002250,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,0,,1,HLA-DQA1
adaptive immune response,GO:0002250,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CD209
adipose tissue development,GO:0060612,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
adipose tissue development,GO:0060612,Tuberculosis,MESH:D014376,1,Ciprofloxacin,0,
adipose tissue development,GO:0060612,"Tuberculosis, Pulmonary",MESH:D014397,3,Air Pollutants|Arsenic|Particulate Matter,0,
adipose tissue development,GO:0060612,"Tuberculosis, Spinal",MESH:D014399,1,Ciprofloxacin,0,
adult locomotory behavior,GO:0008344,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
adult locomotory behavior,GO:0008344,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
aerobic respiration,GO:0009060,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
aerobic respiration,GO:0009060,"Tuberculosis, Pulmonary",MESH:D014397,3,Air Pollutants|Arsenic|Particulate Matter,0,
aldehyde biosynthetic process,GO:0046184,Tuberculosis,MESH:D014376,1,Tretinoin,0,
alpha-amino acid metabolic process,GO:1901605,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
amine metabolic process,GO:0009308,Paratuberculosis,MESH:D010283,0,,1,AOC3
amino acid biosynthetic process,GO:0008652,Tuberculosis,MESH:D014376,1,Pyrazinamide,0,
amino acid biosynthetic process,GO:0008652,"Tuberculosis, Central Nervous System",MESH:D020306,1,Pyrazinamide,0,
amino acid biosynthetic process,GO:0008652,"Tuberculosis, Lymph Node",MESH:D014388,1,Pyrazinamide,0,
amino acid biosynthetic process,GO:0008652,"Tuberculosis, Meningeal",MESH:D014390,1,Pyrazinamide,0,
amino acid biosynthetic process,GO:0008652,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Pyrazinamide,0,
amino acid biosynthetic process,GO:0008652,"Tuberculosis, Pulmonary",MESH:D014397,1,Pyrazinamide,0,
amino acid biosynthetic process,GO:0008652,"Tuberculosis, Spinal",MESH:D014399,1,Pyrazinamide,0,
amino acid metabolic process,GO:0006520,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
amino acid metabolic process,GO:0006520,Tuberculosis,MESH:D014376,1,Tretinoin,0,
amino acid metabolic process,GO:0006520,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
amyloid-beta clearance,GO:0097242,Paratuberculosis,MESH:D010283,0,,1,C3
amyloid-beta metabolic process,GO:0050435,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
amyloid-beta metabolic process,GO:0050435,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
amyloid fibril formation,GO:1990000,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
amyloid fibril formation,GO:1990000,Paratuberculosis,MESH:D010283,0,,1,GSN
amyloid fibril formation,GO:1990000,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
anatomical structure morphogenesis,GO:0009653,Tuberculosis,MESH:D014376,1,Tretinoin,0,
anatomical structure regression,GO:0060033,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
anatomical structure regression,GO:0060033,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
androgen metabolic process,GO:0008209,Tuberculosis,MESH:D014376,3,Rifampin|Tretinoin|Verapamil,0,
androgen metabolic process,GO:0008209,"Tuberculosis, Central Nervous System",MESH:D020306,1,Rifampin,0,
androgen metabolic process,GO:0008209,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Rifampin,0,
androgen metabolic process,GO:0008209,"Tuberculosis, Lymph Node",MESH:D014388,1,Rifampin,0,
androgen metabolic process,GO:0008209,"Tuberculosis, Meningeal",MESH:D014390,1,Rifampin,0,
androgen metabolic process,GO:0008209,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Rifampin,0,
androgen metabolic process,GO:0008209,"Tuberculosis, Pleural",MESH:D014396,1,Rifampin,0,
androgen metabolic process,GO:0008209,"Tuberculosis, Pulmonary",MESH:D014397,2,Clarithromycin|Rifampin,0,
androgen metabolic process,GO:0008209,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
androgen metabolic process,GO:0008209,"Tuberculosis, Spinal",MESH:D014399,1,Rifampin,0,
angiogenesis,GO:0001525,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
angiogenesis,GO:0001525,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
angiogenesis,GO:0001525,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,1,CCL2
animal organ morphogenesis,GO:0009887,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
animal organ morphogenesis,GO:0009887,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
animal organ morphogenesis,GO:0009887,Tuberculosis,MESH:D014376,1,Isoniazid,0,
animal organ morphogenesis,GO:0009887,"Tuberculosis, Central Nervous System",MESH:D020306,1,Isoniazid,0,
animal organ morphogenesis,GO:0009887,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Isoniazid,0,
animal organ morphogenesis,GO:0009887,"Tuberculosis, Lymph Node",MESH:D014388,1,Isoniazid,0,
animal organ morphogenesis,GO:0009887,"Tuberculosis, Meningeal",MESH:D014390,1,Isoniazid,0,
animal organ morphogenesis,GO:0009887,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Isoniazid,0,
animal organ morphogenesis,GO:0009887,"Tuberculosis, Pleural",MESH:D014396,1,Isoniazid,0,
animal organ morphogenesis,GO:0009887,"Tuberculosis, Pulmonary",MESH:D014397,1,Isoniazid,1,CCL2
animal organ morphogenesis,GO:0009887,"Tuberculosis, Spinal",MESH:D014399,1,Isoniazid,0,
animal organ regeneration,GO:0031100,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
animal organ regeneration,GO:0031100,Tuberculosis,MESH:D014376,0,,1,HP
animal organ regeneration,GO:0031100,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CCL2
anoikis,GO:0043276,Tuberculosis,MESH:D014376,1,Tretinoin,0,
antibacterial humoral response,GO:0019731,Paratuberculosis,MESH:D010283,0,,1,TF
antibacterial peptide biosynthetic process,GO:0002780,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,MMP7
antibacterial peptide secretion,GO:0002779,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,MMP7
antibiotic metabolic process,GO:0016999,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
antibiotic metabolic process,GO:0016999,Tuberculosis,MESH:D014376,1,Isoniazid,0,
antibiotic metabolic process,GO:0016999,"Tuberculosis, Central Nervous System",MESH:D020306,1,Isoniazid,0,
antibiotic metabolic process,GO:0016999,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Isoniazid,0,
antibiotic metabolic process,GO:0016999,"Tuberculosis, Lymph Node",MESH:D014388,1,Isoniazid,0,
antibiotic metabolic process,GO:0016999,"Tuberculosis, Meningeal",MESH:D014390,1,Isoniazid,0,
antibiotic metabolic process,GO:0016999,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Isoniazid,0,
antibiotic metabolic process,GO:0016999,"Tuberculosis, Pleural",MESH:D014396,1,Isoniazid,0,
antibiotic metabolic process,GO:0016999,"Tuberculosis, Pulmonary",MESH:D014397,1,Isoniazid,0,
antibiotic metabolic process,GO:0016999,"Tuberculosis, Spinal",MESH:D014399,1,Isoniazid,0,
antigen processing and presentation,GO:0019882,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,2,CD209|IFNG
antigen processing and presentation,GO:0019882,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CD209
antigen processing and presentation of peptide antigen,GO:0048002,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,SLC11A1
antigen processing and presentation of peptide antigen,GO:0048002,Tuberculosis,MESH:D014376,0,,1,SLC11A1
antimicrobial humoral immune response mediated by antimicrobial peptide,GO:0061844,Paratuberculosis,MESH:D010283,0,,1,F2
antimicrobial humoral response,GO:0019730,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,SLC11A1
antimicrobial humoral response,GO:0019730,Tuberculosis,MESH:D014376,0,,1,SLC11A1
apical dendrite morphogenesis,GO:0150021,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
apical dendrite morphogenesis,GO:0150021,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
apoptosome assembly,GO:0097314,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
apoptotic cell clearance,GO:0043277,Tuberculosis,MESH:D014376,1,Ciprofloxacin,0,
apoptotic cell clearance,GO:0043277,"Tuberculosis, Spinal",MESH:D014399,1,Ciprofloxacin,0,
apoptotic chromosome condensation,GO:0030263,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
apoptotic chromosome condensation,GO:0030263,Tuberculosis,MESH:D014376,1,Verapamil,0,
apoptotic chromosome condensation,GO:0030263,"Tuberculosis, Pulmonary",MESH:D014397,6,Air Pollutants|Arsenic|Carbon Monoxide|Nitrogen Dioxide|Particulate Matter|Sulfur Dioxide,0,
apoptotic DNA fragmentation,GO:0006309,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
apoptotic DNA fragmentation,GO:0006309,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
apoptotic DNA fragmentation,GO:0006309,Tuberculosis,MESH:D014376,5,Chenodeoxycholic Acid|Isoniazid|Prednisolone|Tretinoin|Verapamil,0,
apoptotic DNA fragmentation,GO:0006309,"Tuberculosis, Central Nervous System",MESH:D020306,1,Isoniazid,0,
apoptotic DNA fragmentation,GO:0006309,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Isoniazid,0,
apoptotic DNA fragmentation,GO:0006309,"Tuberculosis, Lymph Node",MESH:D014388,1,Isoniazid,0,
apoptotic DNA fragmentation,GO:0006309,"Tuberculosis, Meningeal",MESH:D014390,1,Isoniazid,0,
apoptotic DNA fragmentation,GO:0006309,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Isoniazid,0,
apoptotic DNA fragmentation,GO:0006309,"Tuberculosis, Osteoarticular",MESH:D014394,1,Prednisolone,0,
apoptotic DNA fragmentation,GO:0006309,"Tuberculosis, Pleural",MESH:D014396,1,Isoniazid,0,
apoptotic DNA fragmentation,GO:0006309,"Tuberculosis, Pulmonary",MESH:D014397,2,Isoniazid|Particulate Matter,0,
apoptotic DNA fragmentation,GO:0006309,"Tuberculosis, Spinal",MESH:D014399,1,Isoniazid,0,
apoptotic nuclear changes,GO:0030262,Tuberculosis,MESH:D014376,2,Pyrroles|Triazoles,0,
apoptotic process,GO:0006915,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
apoptotic process,GO:0006915,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,3,IFNG|SP110|TLR2
apoptotic process,GO:0006915,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
apoptotic process,GO:0006915,Paratuberculosis,MESH:D010283,0,,1,TF
apoptotic process,GO:0006915,Tuberculosis,MESH:D014376,13,Amikacin|Chenodeoxycholic Acid|Ciprofloxacin|Gentamicins|Iron|Isoniazid|Ofloxacin|Prednisolone|Pyrazinamide|Rifampin|Tretinoin|Verapamil|Vitamin K 2,0,
apoptotic process,GO:0006915,"Tuberculosis, Central Nervous System",MESH:D020306,3,Isoniazid|Pyrazinamide|Rifampin,0,
apoptotic process,GO:0006915,"Tuberculosis, Gastrointestinal",MESH:D014385,2,Isoniazid|Rifampin,0,
apoptotic process,GO:0006915,"Tuberculosis, Lymph Node",MESH:D014388,4,Isoniazid|Ofloxacin|Pyrazinamide|Rifampin,0,
apoptotic process,GO:0006915,"Tuberculosis, Meningeal",MESH:D014390,3,Isoniazid|Pyrazinamide|Rifampin,0,
apoptotic process,GO:0006915,"Tuberculosis, Multidrug-Resistant",MESH:D018088,4,Isoniazid|Ofloxacin|Pyrazinamide|Rifampin,0,
apoptotic process,GO:0006915,"Tuberculosis, Osteoarticular",MESH:D014394,2,Ofloxacin|Prednisolone,0,
apoptotic process,GO:0006915,"Tuberculosis, Pleural",MESH:D014396,2,Isoniazid|Rifampin,0,
apoptotic process,GO:0006915,"Tuberculosis, Pulmonary",MESH:D014397,11,Air Pollutants|Arsenic|Carbon Monoxide|Clarithromycin|Isoniazid|Nitrogen Dioxide|Ofloxacin|Particulate Matter|Pyrazinamide|Rifampin|Sulfur Dioxide,0,
apoptotic process,GO:0006915,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
apoptotic process,GO:0006915,"Tuberculosis, Spinal",MESH:D014399,4,Ciprofloxacin|Isoniazid|Pyrazinamide|Rifampin,0,
arachidonic acid metabolic process,GO:0019369,Tuberculosis,MESH:D014376,1,Chenodeoxycholic Acid,0,
arginine metabolic process,GO:0006525,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
arginine metabolic process,GO:0006525,"Tuberculosis, Pulmonary",MESH:D014397,3,Air Pollutants|Nitrogen Dioxide|Particulate Matter,0,
arsenite transport,GO:0015700,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
artery smooth muscle contraction,GO:0014824,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
artery smooth muscle contraction,GO:0014824,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
artery vasodilation involved in baroreceptor response to increased systemic arterial blood pressure,GO:0001984,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
artery vasodilation involved in baroreceptor response to increased systemic arterial blood pressure,GO:0001984,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
asparagine metabolic process,GO:0006528,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
asparagine metabolic process,GO:0006528,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
aspartate metabolic process,GO:0006531,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
aspartate metabolic process,GO:0006531,"Tuberculosis, Pulmonary",MESH:D014397,3,Air Pollutants|Nitrogen Dioxide|Particulate Matter,0,
astrocyte activation,GO:0048143,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,2,IFNG|IFNGR1
astrocyte activation,GO:0048143,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
astrocyte activation,GO:0048143,Tuberculosis,MESH:D014376,1,Tretinoin,0,
astrocyte activation,GO:0048143,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
astrocyte cell migration,GO:0043615,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
astrocyte cell migration,GO:0043615,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
astrocyte cell migration,GO:0043615,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,1,CCL2
astrocyte development,GO:0014002,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
ATP biosynthetic process,GO:0006754,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
ATP biosynthetic process,GO:0006754,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
ATP biosynthetic process,GO:0006754,Tuberculosis,MESH:D014376,3,Isoniazid|Rifampin|Verapamil,0,
ATP biosynthetic process,GO:0006754,"Tuberculosis, Central Nervous System",MESH:D020306,2,Isoniazid|Rifampin,0,
ATP biosynthetic process,GO:0006754,"Tuberculosis, Gastrointestinal",MESH:D014385,2,Isoniazid|Rifampin,0,
ATP biosynthetic process,GO:0006754,"Tuberculosis, Lymph Node",MESH:D014388,2,Isoniazid|Rifampin,0,
ATP biosynthetic process,GO:0006754,"Tuberculosis, Meningeal",MESH:D014390,2,Isoniazid|Rifampin,0,
ATP biosynthetic process,GO:0006754,"Tuberculosis, Multidrug-Resistant",MESH:D018088,3,Gatifloxacin|Isoniazid|Rifampin,0,
ATP biosynthetic process,GO:0006754,"Tuberculosis, Pleural",MESH:D014396,2,Isoniazid|Rifampin,0,
ATP biosynthetic process,GO:0006754,"Tuberculosis, Pulmonary",MESH:D014397,5,Air Pollutants|Carbon Monoxide|Isoniazid|Particulate Matter|Rifampin,0,
ATP biosynthetic process,GO:0006754,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
ATP biosynthetic process,GO:0006754,"Tuberculosis, Spinal",MESH:D014399,2,Isoniazid|Rifampin,0,
ATP metabolic process,GO:0046034,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
ATP metabolic process,GO:0046034,Tuberculosis,MESH:D014376,2,Rifampin|Tretinoin,0,
ATP metabolic process,GO:0046034,"Tuberculosis, Central Nervous System",MESH:D020306,1,Rifampin,0,
ATP metabolic process,GO:0046034,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Rifampin,0,
ATP metabolic process,GO:0046034,"Tuberculosis, Lymph Node",MESH:D014388,1,Rifampin,0,
ATP metabolic process,GO:0046034,"Tuberculosis, Meningeal",MESH:D014390,1,Rifampin,0,
ATP metabolic process,GO:0046034,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Rifampin,0,
ATP metabolic process,GO:0046034,"Tuberculosis, Pleural",MESH:D014396,1,Rifampin,0,
ATP metabolic process,GO:0046034,"Tuberculosis, Pulmonary",MESH:D014397,6,Air Pollutants|Arsenic|Nitrogen Dioxide|Particulate Matter|Rifampin|Sulfur Dioxide,0,
ATP metabolic process,GO:0046034,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
ATP metabolic process,GO:0046034,"Tuberculosis, Spinal",MESH:D014399,1,Rifampin,0,
atrial cardiac muscle cell differentiation,GO:0055011,Tuberculosis,MESH:D014376,1,Tretinoin,0,
auditory behavior,GO:0031223,Tuberculosis,MESH:D014376,1,Gentamicins,0,
autophagosome assembly,GO:0000045,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,IRGM
autophagosome assembly,GO:0000045,Tuberculosis,MESH:D014376,1,Rifampin,0,
autophagosome assembly,GO:0000045,"Tuberculosis, Central Nervous System",MESH:D020306,1,Rifampin,0,
autophagosome assembly,GO:0000045,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Rifampin,0,
autophagosome assembly,GO:0000045,"Tuberculosis, Lymph Node",MESH:D014388,1,Rifampin,0,
autophagosome assembly,GO:0000045,"Tuberculosis, Meningeal",MESH:D014390,1,Rifampin,0,
autophagosome assembly,GO:0000045,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Rifampin,0,
autophagosome assembly,GO:0000045,"Tuberculosis, Pleural",MESH:D014396,1,Rifampin,0,
autophagosome assembly,GO:0000045,"Tuberculosis, Pulmonary",MESH:D014397,2,Arsenic|Rifampin,0,
autophagosome assembly,GO:0000045,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
autophagosome assembly,GO:0000045,"Tuberculosis, Spinal",MESH:D014399,1,Rifampin,0,
autophagosome maturation,GO:0097352,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,IRGM
autophagosome maturation,GO:0097352,Tuberculosis,MESH:D014376,1,Chenodeoxycholic Acid,0,
autophagy,GO:0006914,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
autophagy,GO:0006914,Tuberculosis,MESH:D014376,3,Iron|Rifampin|Tretinoin,0,
autophagy,GO:0006914,"Tuberculosis, Bovine",MESH:D014380,0,,1,IL4
autophagy,GO:0006914,"Tuberculosis, Central Nervous System",MESH:D020306,1,Rifampin,0,
autophagy,GO:0006914,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Rifampin,0,
autophagy,GO:0006914,"Tuberculosis, Lymph Node",MESH:D014388,1,Rifampin,0,
autophagy,GO:0006914,"Tuberculosis, Meningeal",MESH:D014390,1,Rifampin,0,
autophagy,GO:0006914,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Rifampin,0,
autophagy,GO:0006914,"Tuberculosis, Pleural",MESH:D014396,1,Rifampin,0,
autophagy,GO:0006914,"Tuberculosis, Pulmonary",MESH:D014397,3,Arsenic|Particulate Matter|Rifampin,0,
autophagy,GO:0006914,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
autophagy,GO:0006914,"Tuberculosis, Spinal",MESH:D014399,1,Rifampin,0,
axon arborization,GO:0140060,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
axon arborization,GO:0140060,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
axonogenesis,GO:0007409,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
axonogenesis,GO:0007409,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
barbed-end actin filament capping,GO:0051016,Paratuberculosis,MESH:D010283,0,,1,GSN
B cell activation,GO:0042113,Paratuberculosis,MESH:D010283,0,,1,C3
B cell activation,GO:0042113,"Tuberculosis, Bovine",MESH:D014380,0,,1,IL4
B cell adhesion,GO:0097323,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CD209
B cell adhesion,GO:0097323,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CD209
B cell costimulation,GO:0031296,"Tuberculosis, Bovine",MESH:D014380,0,,1,IL4
B cell differentiation,GO:0030183,"Tuberculosis, Bovine",MESH:D014380,0,,1,IL4
B cell homeostasis,GO:0001782,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
B cell homeostasis,GO:0001782,"Tuberculosis, Pulmonary",MESH:D014397,3,Air Pollutants|Nitrogen Dioxide|Particulate Matter,0,
B cell proliferation,GO:0042100,"Tuberculosis, Bovine",MESH:D014380,0,,1,IL4
behavior,GO:0007610,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
behavior,GO:0007610,"Tuberculosis, Pulmonary",MESH:D014397,3,Air Pollutants|Arsenic|Particulate Matter,0,
behavioral response to cocaine,GO:0048148,Tuberculosis,MESH:D014376,1,Tretinoin,0,
behavioral response to pain,GO:0048266,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
beta-alanine metabolic process,GO:0019482,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
beta-alanine metabolic process,GO:0019482,"Tuberculosis, Pulmonary",MESH:D014397,3,Air Pollutants|Nitrogen Dioxide|Particulate Matter,0,
bile acid and bile salt transport,GO:0015721,Tuberculosis,MESH:D014376,1,Chenodeoxycholic Acid,0,
bile acid biosynthetic process,GO:0006699,Tuberculosis,MESH:D014376,1,Chenodeoxycholic Acid,0,
bile acid metabolic process,GO:0008206,Extensively Drug-Resistant Tuberculosis,MESH:D054908,1,Ethambutol,0,
bile acid metabolic process,GO:0008206,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
bile acid metabolic process,GO:0008206,Tuberculosis,MESH:D014376,5,Chenodeoxycholic Acid|Ethambutol|Isoniazid|Pyrazinamide|Rifampin,0,
bile acid metabolic process,GO:0008206,"Tuberculosis, Central Nervous System",MESH:D020306,4,Ethambutol|Isoniazid|Pyrazinamide|Rifampin,0,
bile acid metabolic process,GO:0008206,"Tuberculosis, Gastrointestinal",MESH:D014385,2,Isoniazid|Rifampin,0,
bile acid metabolic process,GO:0008206,"Tuberculosis, Lymph Node",MESH:D014388,4,Ethambutol|Isoniazid|Pyrazinamide|Rifampin,0,
bile acid metabolic process,GO:0008206,"Tuberculosis, Meningeal",MESH:D014390,3,Isoniazid|Pyrazinamide|Rifampin,0,
bile acid metabolic process,GO:0008206,"Tuberculosis, Miliary",MESH:D014391,1,Ethambutol,0,
bile acid metabolic process,GO:0008206,"Tuberculosis, Multidrug-Resistant",MESH:D018088,4,Ethambutol|Isoniazid|Pyrazinamide|Rifampin,0,
bile acid metabolic process,GO:0008206,"Tuberculosis, Osteoarticular",MESH:D014394,1,Ethambutol,0,
bile acid metabolic process,GO:0008206,"Tuberculosis, Pleural",MESH:D014396,3,Ethambutol|Isoniazid|Rifampin,0,
bile acid metabolic process,GO:0008206,"Tuberculosis, Pulmonary",MESH:D014397,5,Arsenic|Ethambutol|Isoniazid|Pyrazinamide|Rifampin,0,
bile acid metabolic process,GO:0008206,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
bile acid metabolic process,GO:0008206,"Tuberculosis, Spinal",MESH:D014399,4,Ethambutol|Isoniazid|Pyrazinamide|Rifampin,0,
bile acid secretion,GO:0032782,Tuberculosis,MESH:D014376,3,Chenodeoxycholic Acid|Pyrazinamide|Rifampin,0,
bile acid secretion,GO:0032782,"Tuberculosis, Central Nervous System",MESH:D020306,2,Pyrazinamide|Rifampin,0,
bile acid secretion,GO:0032782,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Rifampin,0,
bile acid secretion,GO:0032782,"Tuberculosis, Lymph Node",MESH:D014388,2,Pyrazinamide|Rifampin,0,
bile acid secretion,GO:0032782,"Tuberculosis, Meningeal",MESH:D014390,2,Pyrazinamide|Rifampin,0,
bile acid secretion,GO:0032782,"Tuberculosis, Multidrug-Resistant",MESH:D018088,2,Pyrazinamide|Rifampin,0,
bile acid secretion,GO:0032782,"Tuberculosis, Pleural",MESH:D014396,1,Rifampin,0,
bile acid secretion,GO:0032782,"Tuberculosis, Pulmonary",MESH:D014397,2,Pyrazinamide|Rifampin,0,
bile acid secretion,GO:0032782,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
bile acid secretion,GO:0032782,"Tuberculosis, Spinal",MESH:D014399,2,Pyrazinamide|Rifampin,0,
bilirubin transport,GO:0015723,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
bilirubin transport,GO:0015723,Tuberculosis,MESH:D014376,3,Isoniazid|Prednisolone|Rifampin,0,
bilirubin transport,GO:0015723,"Tuberculosis, Central Nervous System",MESH:D020306,2,Isoniazid|Rifampin,0,
bilirubin transport,GO:0015723,"Tuberculosis, Gastrointestinal",MESH:D014385,2,Isoniazid|Rifampin,0,
bilirubin transport,GO:0015723,"Tuberculosis, Lymph Node",MESH:D014388,2,Isoniazid|Rifampin,0,
bilirubin transport,GO:0015723,"Tuberculosis, Meningeal",MESH:D014390,2,Isoniazid|Rifampin,0,
bilirubin transport,GO:0015723,"Tuberculosis, Multidrug-Resistant",MESH:D018088,2,Isoniazid|Rifampin,0,
bilirubin transport,GO:0015723,"Tuberculosis, Osteoarticular",MESH:D014394,1,Prednisolone,0,
bilirubin transport,GO:0015723,"Tuberculosis, Pleural",MESH:D014396,2,Isoniazid|Rifampin,0,
bilirubin transport,GO:0015723,"Tuberculosis, Pulmonary",MESH:D014397,3,Arsenic|Isoniazid|Rifampin,0,
bilirubin transport,GO:0015723,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
bilirubin transport,GO:0015723,"Tuberculosis, Spinal",MESH:D014399,2,Isoniazid|Rifampin,0,
biological_process,GO:0008150,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,3,IFNGR1|SLC11A1|TIRAP
biological_process,GO:0008150,Paratuberculosis,MESH:D010283,0,,1,C1R
biological_process,GO:0008150,Tuberculosis,MESH:D014376,0,,3,CORO1A|SLC11A1|TIRAP
biological process involved in interspecies interaction between organisms,GO:0044419,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CD209
biological process involved in interspecies interaction between organisms,GO:0044419,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CD209
biological process involved in symbiotic interaction,GO:0044403,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
biosynthetic process of antibacterial peptides active against Gram-positive bacteria,GO:0002815,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
biosynthetic process of antibacterial peptides active against Gram-positive bacteria,GO:0002815,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
blastocyst development,GO:0001824,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
blastocyst development,GO:0001824,Tuberculosis,MESH:D014376,1,Isoniazid,0,
blastocyst development,GO:0001824,"Tuberculosis, Central Nervous System",MESH:D020306,1,Isoniazid,0,
blastocyst development,GO:0001824,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Isoniazid,0,
blastocyst development,GO:0001824,"Tuberculosis, Lymph Node",MESH:D014388,1,Isoniazid,0,
blastocyst development,GO:0001824,"Tuberculosis, Meningeal",MESH:D014390,1,Isoniazid,0,
blastocyst development,GO:0001824,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Isoniazid,0,
blastocyst development,GO:0001824,"Tuberculosis, Pleural",MESH:D014396,1,Isoniazid,0,
blastocyst development,GO:0001824,"Tuberculosis, Pulmonary",MESH:D014397,1,Isoniazid,0,
blastocyst development,GO:0001824,"Tuberculosis, Spinal",MESH:D014399,1,Isoniazid,0,
blastocyst formation,GO:0001825,Tuberculosis,MESH:D014376,1,Tretinoin,0,
blastocyst formation,GO:0001825,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
bleb assembly,GO:0032060,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
blood circulation,GO:0008015,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
blood circulation,GO:0008015,Tuberculosis,MESH:D014376,1,Tretinoin,0,
blood circulation,GO:0008015,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
blood coagulation,GO:0007596,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,IFNGR1
blood coagulation,GO:0007596,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
blood coagulation,GO:0007596,Paratuberculosis,MESH:D010283,0,,2,F2|TF
blood coagulation,GO:0007596,Tuberculosis,MESH:D014376,1,Rifampin,0,
blood coagulation,GO:0007596,"Tuberculosis, Central Nervous System",MESH:D020306,1,Rifampin,0,
blood coagulation,GO:0007596,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Rifampin,0,
blood coagulation,GO:0007596,"Tuberculosis, Lymph Node",MESH:D014388,1,Rifampin,0,
blood coagulation,GO:0007596,"Tuberculosis, Meningeal",MESH:D014390,1,Rifampin,0,
blood coagulation,GO:0007596,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Rifampin,0,
blood coagulation,GO:0007596,"Tuberculosis, Pleural",MESH:D014396,1,Rifampin,0,
blood coagulation,GO:0007596,"Tuberculosis, Pulmonary",MESH:D014397,3,Air Pollutants|Particulate Matter|Rifampin,0,
blood coagulation,GO:0007596,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
blood coagulation,GO:0007596,"Tuberculosis, Spinal",MESH:D014399,1,Rifampin,0,
"blood coagulation, fibrin clot formation",GO:0072378,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
"blood coagulation, fibrin clot formation",GO:0072378,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
blood vessel development,GO:0001568,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
blood vessel development,GO:0001568,"Tuberculosis, Pulmonary",MESH:D014397,3,Air Pollutants|Arsenic|Particulate Matter,0,
blood vessel diameter maintenance,GO:0097746,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
blood vessel diameter maintenance,GO:0097746,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
bone development,GO:0060348,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
bone development,GO:0060348,Tuberculosis,MESH:D014376,1,Prednisolone,0,
bone development,GO:0060348,"Tuberculosis, Osteoarticular",MESH:D014394,1,Prednisolone,0,
bone development,GO:0060348,"Tuberculosis, Pulmonary",MESH:D014397,3,Arsenic|Nitrogen Dioxide|Particulate Matter,0,
bone growth,GO:0098868,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
bone growth,GO:0098868,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
bone mineralization,GO:0030282,Tuberculosis,MESH:D014376,1,Prednisolone,0,
bone mineralization,GO:0030282,"Tuberculosis, Osteoarticular",MESH:D014394,1,Prednisolone,0,
bone regeneration,GO:1990523,Tuberculosis,MESH:D014376,1,Vitamin K 2,0,
bone resorption,GO:0045453,Tuberculosis,MESH:D014376,2,Iron|Vitamin K 2,0,
brain development,GO:0007420,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
brain development,GO:0007420,Tuberculosis,MESH:D014376,0,,1,CORO1A
brain development,GO:0007420,"Tuberculosis, Pulmonary",MESH:D014397,3,Air Pollutants|Arsenic|Particulate Matter,0,
bronchiole development,GO:0060435,Tuberculosis,MESH:D014376,1,Tretinoin,0,
brown fat cell proliferation,GO:0070342,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
brown fat cell proliferation,GO:0070342,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
bud outgrowth involved in lung branching,GO:0060447,Tuberculosis,MESH:D014376,1,Tretinoin,0,
butyrate metabolic process,GO:0019605,Tuberculosis,MESH:D014376,1,Tretinoin,0,
C-5 methylation of cytosine,GO:0090116,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
C-5 methylation of cytosine,GO:0090116,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
cadmium ion transmembrane transport,GO:0070574,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,SLC11A1
cadmium ion transmembrane transport,GO:0070574,Tuberculosis,MESH:D014376,0,,1,SLC11A1
calcium ion homeostasis,GO:0055074,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
calcium ion homeostasis,GO:0055074,Tuberculosis,MESH:D014376,2,Isoniazid|Verapamil,0,
calcium ion homeostasis,GO:0055074,"Tuberculosis, Central Nervous System",MESH:D020306,1,Isoniazid,0,
calcium ion homeostasis,GO:0055074,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Isoniazid,0,
calcium ion homeostasis,GO:0055074,"Tuberculosis, Lymph Node",MESH:D014388,1,Isoniazid,0,
calcium ion homeostasis,GO:0055074,"Tuberculosis, Meningeal",MESH:D014390,1,Isoniazid,0,
calcium ion homeostasis,GO:0055074,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Isoniazid,0,
calcium ion homeostasis,GO:0055074,"Tuberculosis, Pleural",MESH:D014396,1,Isoniazid,0,
calcium ion homeostasis,GO:0055074,"Tuberculosis, Pulmonary",MESH:D014397,1,Isoniazid,0,
calcium ion homeostasis,GO:0055074,"Tuberculosis, Spinal",MESH:D014399,1,Isoniazid,0,
calcium ion import,GO:0070509,Tuberculosis,MESH:D014376,1,Verapamil,0,
calcium ion transport,GO:0006816,Tuberculosis,MESH:D014376,0,,1,CORO1A
calcium-mediated signaling,GO:0019722,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
calcium-mediated signaling,GO:0019722,Tuberculosis,MESH:D014376,2,Gentamicins|Verapamil,0,
calcium-mediated signaling,GO:0019722,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
CAMKK-AMPK signaling cascade,GO:0061762,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,IRGM
cAMP biosynthetic process,GO:0006171,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
cAMP biosynthetic process,GO:0006171,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
cAMP metabolic process,GO:0046058,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
cAMP metabolic process,GO:0046058,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
canalicular bile acid transport,GO:0015722,Tuberculosis,MESH:D014376,1,Chenodeoxycholic Acid,0,
cardiac muscle cell contraction,GO:0086003,Paratuberculosis,MESH:D010283,0,,1,GSN
cardiac muscle cell contraction,GO:0086003,Tuberculosis,MESH:D014376,1,Verapamil,0,
cardiac muscle cell differentiation,GO:0055007,Tuberculosis,MESH:D014376,1,Tretinoin,0,
cardiac muscle contraction,GO:0060048,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
cardiac muscle contraction,GO:0060048,Tuberculosis,MESH:D014376,1,Iron,0,
cardiac muscle contraction,GO:0060048,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
carnitine transmembrane transport,GO:1902603,Tuberculosis,MESH:D014376,1,Verapamil,0,
"CD4-positive, alpha-beta T cell activation",GO:0035710,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
"CD4-positive, alpha-beta T cell activation",GO:0035710,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
"CD4-positive, alpha-beta T cell lineage commitment",GO:0043373,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
"CD8-positive, alpha-beta T cell differentiation",GO:0043374,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,0,,1,TNFSF8
"CD8-positive, alpha-beta T cell differentiation",GO:0043374,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
"CD8-positive, alpha-beta T cell differentiation involved in immune response",GO:0002302,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,IFNG
"CD8-positive, alpha-beta T cell lineage commitment",GO:0043375,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
cell adhesion,GO:0007155,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
cell adhesion,GO:0007155,Paratuberculosis,MESH:D010283,0,,2,AOC3|F2
cell adhesion,GO:0007155,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CCL2
cell aggregation,GO:0098743,Tuberculosis,MESH:D014376,1,bedaquiline,0,
cell aggregation,GO:0098743,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,bedaquiline,0,
cell-cell adhesion,GO:0098609,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
cell-cell adhesion via plasma-membrane adhesion molecules,GO:0098742,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
cell-cell adhesion via plasma-membrane adhesion molecules,GO:0098742,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
cell-cell recognition,GO:0009988,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CD209
cell-cell recognition,GO:0009988,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CD209
cell-cell signaling,GO:0007267,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,0,,1,TNFSF8
cell-cell signaling via exosome,GO:0099156,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
cell chemotaxis,GO:0060326,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
cell chemotaxis,GO:0060326,Tuberculosis,MESH:D014376,2,Rifampin|Tretinoin,0,
cell chemotaxis,GO:0060326,"Tuberculosis, Central Nervous System",MESH:D020306,1,Rifampin,0,
cell chemotaxis,GO:0060326,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Rifampin,0,
cell chemotaxis,GO:0060326,"Tuberculosis, Lymph Node",MESH:D014388,1,Rifampin,0,
cell chemotaxis,GO:0060326,"Tuberculosis, Meningeal",MESH:D014390,1,Rifampin,0,
cell chemotaxis,GO:0060326,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Rifampin,0,
cell chemotaxis,GO:0060326,"Tuberculosis, Pleural",MESH:D014396,1,Rifampin,0,
cell chemotaxis,GO:0060326,"Tuberculosis, Pulmonary",MESH:D014397,3,Arsenic|Particulate Matter|Rifampin,0,
cell chemotaxis,GO:0060326,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
cell chemotaxis,GO:0060326,"Tuberculosis, Spinal",MESH:D014399,1,Rifampin,0,
cell communication,GO:0007154,Tuberculosis,MESH:D014376,1,Tretinoin,0,
cell cycle,GO:0007049,Tuberculosis,MESH:D014376,5,Chenodeoxycholic Acid|Ciprofloxacin|Prednisolone|Rifampin|Tretinoin,0,
cell cycle,GO:0007049,"Tuberculosis, Central Nervous System",MESH:D020306,1,Rifampin,0,
cell cycle,GO:0007049,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Rifampin,0,
cell cycle,GO:0007049,"Tuberculosis, Lymph Node",MESH:D014388,1,Rifampin,0,
cell cycle,GO:0007049,"Tuberculosis, Meningeal",MESH:D014390,1,Rifampin,0,
cell cycle,GO:0007049,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Rifampin,0,
cell cycle,GO:0007049,"Tuberculosis, Osteoarticular",MESH:D014394,1,Prednisolone,0,
cell cycle,GO:0007049,"Tuberculosis, Pleural",MESH:D014396,1,Rifampin,0,
cell cycle,GO:0007049,"Tuberculosis, Pulmonary",MESH:D014397,1,Rifampin,0,
cell cycle,GO:0007049,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
cell cycle,GO:0007049,"Tuberculosis, Spinal",MESH:D014399,2,Ciprofloxacin|Rifampin,0,
cell death,GO:0008219,Latent Tuberculosis,MESH:D055985,2,Isoniazid|Pyridoxine,0,
cell death,GO:0008219,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
cell death,GO:0008219,Tuberculosis,MESH:D014376,10,Gentamicins|Iron|Isoniazid|Kanamycin|Ofloxacin|Pyridoxine|Rifampin|Tretinoin|Triazoles|Verapamil,0,
cell death,GO:0008219,"Tuberculosis, Central Nervous System",MESH:D020306,2,Isoniazid|Rifampin,0,
cell death,GO:0008219,"Tuberculosis, Gastrointestinal",MESH:D014385,2,Isoniazid|Rifampin,0,
cell death,GO:0008219,"Tuberculosis, Lymph Node",MESH:D014388,3,Isoniazid|Ofloxacin|Rifampin,0,
cell death,GO:0008219,"Tuberculosis, Meningeal",MESH:D014390,2,Isoniazid|Rifampin,0,
cell death,GO:0008219,"Tuberculosis, Multidrug-Resistant",MESH:D018088,4,Isoniazid|Kanamycin|Ofloxacin|Rifampin,0,
cell death,GO:0008219,"Tuberculosis, Osteoarticular",MESH:D014394,1,Ofloxacin,0,
cell death,GO:0008219,"Tuberculosis, Pleural",MESH:D014396,2,Isoniazid|Rifampin,0,
cell death,GO:0008219,"Tuberculosis, Pulmonary",MESH:D014397,8,Air Pollutants|Arsenic|Isoniazid|Nitrogen Dioxide|Ofloxacin|Particulate Matter|Pyridoxine|Rifampin,0,
cell death,GO:0008219,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
cell death,GO:0008219,"Tuberculosis, Spinal",MESH:D014399,2,Isoniazid|Rifampin,0,
cell differentiation,GO:0030154,Tuberculosis,MESH:D014376,1,Tretinoin,0,
cell growth,GO:0016049,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
cell growth,GO:0016049,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
cell growth,GO:0016049,Tuberculosis,MESH:D014376,5,Gentamicins|Isoniazid|Tretinoin|Triazoles|Verapamil,0,
cell growth,GO:0016049,"Tuberculosis, Central Nervous System",MESH:D020306,1,Isoniazid,0,
cell growth,GO:0016049,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Isoniazid,0,
cell growth,GO:0016049,"Tuberculosis, Lymph Node",MESH:D014388,1,Isoniazid,0,
cell growth,GO:0016049,"Tuberculosis, Meningeal",MESH:D014390,1,Isoniazid,0,
cell growth,GO:0016049,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Isoniazid,0,
cell growth,GO:0016049,"Tuberculosis, Pleural",MESH:D014396,1,Isoniazid,0,
cell growth,GO:0016049,"Tuberculosis, Pulmonary",MESH:D014397,4,Arsenic|Carbon Monoxide|Isoniazid|Particulate Matter,0,
cell growth,GO:0016049,"Tuberculosis, Spinal",MESH:D014399,1,Isoniazid,0,
cell migration,GO:0016477,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
cell migration,GO:0016477,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
cell migration,GO:0016477,Tuberculosis,MESH:D014376,4,Gentamicins|Isoniazid|Tretinoin|Vitamin K 2,1,CORO1A
cell migration,GO:0016477,"Tuberculosis, Central Nervous System",MESH:D020306,1,Isoniazid,0,
cell migration,GO:0016477,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Isoniazid,0,
cell migration,GO:0016477,"Tuberculosis, Lymph Node",MESH:D014388,1,Isoniazid,0,
cell migration,GO:0016477,"Tuberculosis, Meningeal",MESH:D014390,1,Isoniazid,0,
cell migration,GO:0016477,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Isoniazid,0,
cell migration,GO:0016477,"Tuberculosis, Pleural",MESH:D014396,1,Isoniazid,0,
cell migration,GO:0016477,"Tuberculosis, Pulmonary",MESH:D014397,3,Arsenic|Isoniazid|Particulate Matter,0,
cell migration,GO:0016477,"Tuberculosis, Spinal",MESH:D014399,1,Isoniazid,0,
cell population proliferation,GO:0008283,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
cell population proliferation,GO:0008283,Tuberculosis,MESH:D014376,12,Amikacin|Chenodeoxycholic Acid|Ciprofloxacin|Gentamicins|Iron|Ofloxacin|Prednisolone|Pyrazinamide|Rifampin|Tretinoin|Verapamil|Vitamin K 2,0,
cell population proliferation,GO:0008283,"Tuberculosis, Central Nervous System",MESH:D020306,2,Pyrazinamide|Rifampin,0,
cell population proliferation,GO:0008283,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Rifampin,0,
cell population proliferation,GO:0008283,"Tuberculosis, Lymph Node",MESH:D014388,3,Ofloxacin|Pyrazinamide|Rifampin,0,
cell population proliferation,GO:0008283,"Tuberculosis, Meningeal",MESH:D014390,2,Pyrazinamide|Rifampin,0,
cell population proliferation,GO:0008283,"Tuberculosis, Multidrug-Resistant",MESH:D018088,3,Ofloxacin|Pyrazinamide|Rifampin,0,
cell population proliferation,GO:0008283,"Tuberculosis, Osteoarticular",MESH:D014394,2,Ofloxacin|Prednisolone,0,
cell population proliferation,GO:0008283,"Tuberculosis, Pleural",MESH:D014396,1,Rifampin,0,
cell population proliferation,GO:0008283,"Tuberculosis, Pulmonary",MESH:D014397,7,Air Pollutants|Arsenic|Carbon Monoxide|Ofloxacin|Particulate Matter|Pyrazinamide|Rifampin,0,
cell population proliferation,GO:0008283,"Tuberculosis, Renal",MESH:D014398,2,Adrenal Cortex Hormones|Rifampin,0,
cell population proliferation,GO:0008283,"Tuberculosis, Spinal",MESH:D014399,3,Ciprofloxacin|Pyrazinamide|Rifampin,0,
cell projection assembly,GO:0030031,Paratuberculosis,MESH:D010283,0,,1,GSN
cell projection organization,GO:0030030,Paratuberculosis,MESH:D010283,0,,1,GSN
cell redox homeostasis,GO:0045454,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,SLC11A1
cell redox homeostasis,GO:0045454,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
cell redox homeostasis,GO:0045454,Tuberculosis,MESH:D014376,3,Prednisolone|Pyrazinamide|Tretinoin,1,SLC11A1
cell redox homeostasis,GO:0045454,"Tuberculosis, Central Nervous System",MESH:D020306,1,Pyrazinamide,0,
cell redox homeostasis,GO:0045454,"Tuberculosis, Lymph Node",MESH:D014388,1,Pyrazinamide,0,
cell redox homeostasis,GO:0045454,"Tuberculosis, Meningeal",MESH:D014390,1,Pyrazinamide,0,
cell redox homeostasis,GO:0045454,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Pyrazinamide,0,
cell redox homeostasis,GO:0045454,"Tuberculosis, Osteoarticular",MESH:D014394,1,Prednisolone,0,
cell redox homeostasis,GO:0045454,"Tuberculosis, Pulmonary",MESH:D014397,4,Air Pollutants|Arsenic|Particulate Matter|Pyrazinamide,0,
cell redox homeostasis,GO:0045454,"Tuberculosis, Spinal",MESH:D014399,1,Pyrazinamide,0,
cell-substrate adhesion,GO:0031589,Tuberculosis,MESH:D014376,0,,1,CORO1A
cell surface pattern recognition receptor signaling pathway,GO:0002752,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,TLR2
cell surface receptor signaling pathway,GO:0007166,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,3,CCL2|IFNG|TIRAP
cell surface receptor signaling pathway,GO:0007166,Paratuberculosis,MESH:D010283,0,,1,F2
cell surface receptor signaling pathway,GO:0007166,Tuberculosis,MESH:D014376,0,,1,TIRAP
cell surface receptor signaling pathway,GO:0007166,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CCL2
cellular aldehyde metabolic process,GO:0006081,Tuberculosis,MESH:D014376,1,Tretinoin,0,
cellular calcium ion homeostasis,GO:0006874,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
cellular calcium ion homeostasis,GO:0006874,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
cellular calcium ion homeostasis,GO:0006874,Tuberculosis,MESH:D014376,1,Verapamil,0,
cellular calcium ion homeostasis,GO:0006874,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,1,CCL2
cellular component organization,GO:0016043,Tuberculosis,MESH:D014376,1,Tretinoin,0,
cellular detoxification of cadmium ion,GO:0098849,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,SLC11A1
cellular detoxification of cadmium ion,GO:0098849,Tuberculosis,MESH:D014376,0,,1,SLC11A1
cellular homeostasis,GO:0019725,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
cellular homeostasis,GO:0019725,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CCL2
cellular iron ion homeostasis,GO:0006879,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,SLC11A1
cellular iron ion homeostasis,GO:0006879,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
cellular iron ion homeostasis,GO:0006879,Paratuberculosis,MESH:D010283,0,,1,TF
cellular iron ion homeostasis,GO:0006879,Tuberculosis,MESH:D014376,1,Iron,1,SLC11A1
cellular iron ion homeostasis,GO:0006879,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
cellular lipid catabolic process,GO:0044242,"Tuberculosis, Pulmonary",MESH:D014397,2,Arsenic|Sulfur Dioxide,0,
cellular lipid metabolic process,GO:0044255,Tuberculosis,MESH:D014376,1,Tretinoin,0,
cellular metabolic process,GO:0044237,Extensively Drug-Resistant Tuberculosis,MESH:D054908,1,Ethambutol,0,
cellular metabolic process,GO:0044237,Latent Tuberculosis,MESH:D055985,2,Isoniazid|Pyridoxine,0,
cellular metabolic process,GO:0044237,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
cellular metabolic process,GO:0044237,Tuberculosis,MESH:D014376,11,Ciprofloxacin|Ethambutol|Ethionamide|Gentamicins|Iron|Isoniazid|Pyrazinamide|Pyridoxine|Rifampin|Tretinoin|Verapamil,0,
cellular metabolic process,GO:0044237,"Tuberculosis, Central Nervous System",MESH:D020306,4,Ethambutol|Isoniazid|Pyrazinamide|Rifampin,0,
cellular metabolic process,GO:0044237,"Tuberculosis, Gastrointestinal",MESH:D014385,2,Isoniazid|Rifampin,0,
cellular metabolic process,GO:0044237,"Tuberculosis, Lymph Node",MESH:D014388,4,Ethambutol|Isoniazid|Pyrazinamide|Rifampin,0,
cellular metabolic process,GO:0044237,"Tuberculosis, Meningeal",MESH:D014390,3,Isoniazid|Pyrazinamide|Rifampin,0,
cellular metabolic process,GO:0044237,"Tuberculosis, Miliary",MESH:D014391,1,Ethambutol,0,
cellular metabolic process,GO:0044237,"Tuberculosis, Multidrug-Resistant",MESH:D018088,5,Ethambutol|Ethionamide|Isoniazid|Pyrazinamide|Rifampin,0,
cellular metabolic process,GO:0044237,"Tuberculosis, Osteoarticular",MESH:D014394,1,Ethambutol,0,
cellular metabolic process,GO:0044237,"Tuberculosis, Pleural",MESH:D014396,3,Ethambutol|Isoniazid|Rifampin,0,
cellular metabolic process,GO:0044237,"Tuberculosis, Pulmonary",MESH:D014397,9,Air Pollutants|Arsenic|Clarithromycin|Ethambutol|Isoniazid|Particulate Matter|Pyrazinamide|Pyridoxine|Rifampin,0,
cellular metabolic process,GO:0044237,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
cellular metabolic process,GO:0044237,"Tuberculosis, Spinal",MESH:D014399,5,Ciprofloxacin|Ethambutol|Isoniazid|Pyrazinamide|Rifampin,0,
cellular metal ion homeostasis,GO:0006875,Tuberculosis,MESH:D014376,1,Iron,0,
cellular nitric oxide homeostasis,GO:0033484,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
cellular nitric oxide homeostasis,GO:0033484,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
cellular oxidant detoxification,GO:0098869,Tuberculosis,MESH:D014376,0,,1,HP
cellular respiration,GO:0045333,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
cellular respiration,GO:0045333,Tuberculosis,MESH:D014376,1,Tretinoin,0,
cellular respiration,GO:0045333,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
cellular response to amino acid stimulus,GO:0071230,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,MMP3
cellular response to antibiotic,GO:0071236,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
cellular response to antibiotic,GO:0071236,Tuberculosis,MESH:D014376,1,Isoniazid,0,
cellular response to antibiotic,GO:0071236,"Tuberculosis, Central Nervous System",MESH:D020306,1,Isoniazid,0,
cellular response to antibiotic,GO:0071236,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Isoniazid,0,
cellular response to antibiotic,GO:0071236,"Tuberculosis, Lymph Node",MESH:D014388,1,Isoniazid,0,
cellular response to antibiotic,GO:0071236,"Tuberculosis, Meningeal",MESH:D014390,1,Isoniazid,0,
cellular response to antibiotic,GO:0071236,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Isoniazid,0,
cellular response to antibiotic,GO:0071236,"Tuberculosis, Pleural",MESH:D014396,1,Isoniazid,0,
cellular response to antibiotic,GO:0071236,"Tuberculosis, Pulmonary",MESH:D014397,1,Isoniazid,0,
cellular response to antibiotic,GO:0071236,"Tuberculosis, Spinal",MESH:D014399,1,Isoniazid,0,
cellular response to arsenic-containing substance,GO:0071243,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
cellular response to arsenite(3-),GO:1903841,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
cellular response to ATP,GO:0071318,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
cellular response to ATP,GO:0071318,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CCL2
cellular response to bacterial lipopeptide,GO:0071221,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,2,TIRAP|TLR2
cellular response to bacterial lipopeptide,GO:0071221,Tuberculosis,MESH:D014376,0,,1,TIRAP
cellular response to cadmium ion,GO:0071276,Paratuberculosis,MESH:D010283,0,,1,GSN
cellular response to cAMP,GO:0071320,Paratuberculosis,MESH:D010283,0,,1,TF
cellular response to cell-matrix adhesion,GO:0071460,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,MMP3
cellular response to chemical stimulus,GO:0070887,Tuberculosis,MESH:D014376,1,Tretinoin,0,
cellular response to dexamethasone stimulus,GO:0071549,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
cellular response to dexamethasone stimulus,GO:0071549,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CCL2
cellular response to diacyl bacterial lipopeptide,GO:0071726,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,TLR2
cellular response to DNA damage stimulus,GO:0006974,Extensively Drug-Resistant Tuberculosis,MESH:D054908,1,Ethambutol,0,
cellular response to DNA damage stimulus,GO:0006974,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
cellular response to DNA damage stimulus,GO:0006974,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
cellular response to DNA damage stimulus,GO:0006974,Tuberculosis,MESH:D014376,7,Ciprofloxacin|Ethambutol|Gentamicins|Iron|Isoniazid|Pyrazinamide|Rifampin,0,
cellular response to DNA damage stimulus,GO:0006974,"Tuberculosis, Central Nervous System",MESH:D020306,4,Ethambutol|Isoniazid|Pyrazinamide|Rifampin,0,
cellular response to DNA damage stimulus,GO:0006974,"Tuberculosis, Gastrointestinal",MESH:D014385,2,Isoniazid|Rifampin,0,
cellular response to DNA damage stimulus,GO:0006974,"Tuberculosis, Lymph Node",MESH:D014388,4,Ethambutol|Isoniazid|Pyrazinamide|Rifampin,0,
cellular response to DNA damage stimulus,GO:0006974,"Tuberculosis, Meningeal",MESH:D014390,3,Isoniazid|Pyrazinamide|Rifampin,0,
cellular response to DNA damage stimulus,GO:0006974,"Tuberculosis, Miliary",MESH:D014391,1,Ethambutol,0,
cellular response to DNA damage stimulus,GO:0006974,"Tuberculosis, Multidrug-Resistant",MESH:D018088,4,Ethambutol|Isoniazid|Pyrazinamide|Rifampin,0,
cellular response to DNA damage stimulus,GO:0006974,"Tuberculosis, Osteoarticular",MESH:D014394,1,Ethambutol,0,
cellular response to DNA damage stimulus,GO:0006974,"Tuberculosis, Pleural",MESH:D014396,3,Ethambutol|Isoniazid|Rifampin,0,
cellular response to DNA damage stimulus,GO:0006974,"Tuberculosis, Pulmonary",MESH:D014397,7,Air Pollutants|Arsenic|Ethambutol|Isoniazid|Particulate Matter|Pyrazinamide|Rifampin,0,
cellular response to DNA damage stimulus,GO:0006974,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
cellular response to DNA damage stimulus,GO:0006974,"Tuberculosis, Spinal",MESH:D014399,5,Ciprofloxacin|Ethambutol|Isoniazid|Pyrazinamide|Rifampin,0,
cellular response to estradiol stimulus,GO:0071392,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
cellular response to estradiol stimulus,GO:0071392,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CCL2
cellular response to fatty acid,GO:0071398,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
cellular response to fatty acid,GO:0071398,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CCL2
cellular response to fibroblast growth factor stimulus,GO:0044344,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
cellular response to fibroblast growth factor stimulus,GO:0044344,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CCL2
cellular response to follicle-stimulating hormone stimulus,GO:0071372,Paratuberculosis,MESH:D010283,0,,1,TF
cellular response to gamma radiation,GO:0071480,Tuberculosis,MESH:D014376,1,Tretinoin,0,
cellular response to gamma radiation,GO:0071480,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
cellular response to glucose stimulus,GO:0071333,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
cellular response to glucose stimulus,GO:0071333,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CCL2
cellular response to high density lipoprotein particle stimulus,GO:0071403,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
cellular response to high density lipoprotein particle stimulus,GO:0071403,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CCL2
cellular response to high light intensity,GO:0071486,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
cellular response to high light intensity,GO:0071486,Tuberculosis,MESH:D014376,2,Gentamicins|Isoniazid,0,
cellular response to high light intensity,GO:0071486,"Tuberculosis, Central Nervous System",MESH:D020306,1,Isoniazid,0,
cellular response to high light intensity,GO:0071486,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Isoniazid,0,
cellular response to high light intensity,GO:0071486,"Tuberculosis, Lymph Node",MESH:D014388,1,Isoniazid,0,
cellular response to high light intensity,GO:0071486,"Tuberculosis, Meningeal",MESH:D014390,1,Isoniazid,0,
cellular response to high light intensity,GO:0071486,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Isoniazid,0,
cellular response to high light intensity,GO:0071486,"Tuberculosis, Pleural",MESH:D014396,1,Isoniazid,0,
cellular response to high light intensity,GO:0071486,"Tuberculosis, Pulmonary",MESH:D014397,1,Isoniazid,0,
cellular response to high light intensity,GO:0071486,"Tuberculosis, Spinal",MESH:D014399,1,Isoniazid,0,
cellular response to inorganic substance,GO:0071241,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
cellular response to inorganic substance,GO:0071241,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
cellular response to insulin stimulus,GO:0032869,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
cellular response to insulin stimulus,GO:0032869,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CCL2
cellular response to interferon-beta,GO:0035458,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,IRGM
cellular response to interleukin-1,GO:0071347,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
cellular response to interleukin-1,GO:0071347,"Tuberculosis, Pulmonary",MESH:D014397,0,,2,CCL2|MMP3
cellular response to interleukin-18,GO:0071351,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,IFNG
cellular response to interleukin-4,GO:0071353,Tuberculosis,MESH:D014376,0,,1,CORO1A
cellular response to interleukin-6,GO:0071354,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
cellular response to interleukin-6,GO:0071354,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CCL2
cellular response to iron ion,GO:0071281,Paratuberculosis,MESH:D010283,0,,1,TF
cellular response to lead ion,GO:0071284,Tuberculosis,MESH:D014376,1,Verapamil,0,
cellular response to lipopolysaccharide,GO:0071222,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,3,CCL2|IFNG|IRGM
cellular response to lipopolysaccharide,GO:0071222,"Tuberculosis, Pulmonary",MESH:D014397,0,,3,CCL2|MMP3|MMP8
cellular response to lipoprotein particle stimulus,GO:0071402,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
cellular response to lipoprotein particle stimulus,GO:0071402,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CCL2
cellular response to lipoteichoic acid,GO:0071223,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,2,TIRAP|TLR2
cellular response to lipoteichoic acid,GO:0071223,Tuberculosis,MESH:D014376,0,,1,TIRAP
cellular response to macrophage colony-stimulating factor stimulus,GO:0036006,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
cellular response to macrophage colony-stimulating factor stimulus,GO:0036006,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CCL2
cellular response to mechanical stimulus,GO:0071260,Paratuberculosis,MESH:D010283,0,,1,F2
cellular response to mechanical stimulus,GO:0071260,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,MMP7
cellular response to mercury ion,GO:0071288,"Tuberculosis, Bovine",MESH:D014380,0,,1,IL4
cellular response to nitric oxide,GO:0071732,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,MMP3
cellular response to nitrosative stress,GO:0071500,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
cellular response to nitrosative stress,GO:0071500,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
cellular response to osmotic stress,GO:0071470,Tuberculosis,MESH:D014376,1,Verapamil,0,
cellular response to oxidative stress,GO:0034599,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
cellular response to oxidative stress,GO:0034599,"Tuberculosis, Pulmonary",MESH:D014397,5,Air Pollutants|Arsenic|Carbon Monoxide|Nitrogen Dioxide|Particulate Matter,0,
cellular response to peptidoglycan,GO:0071224,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,TLR2
cellular response to platelet-derived growth factor stimulus,GO:0036120,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
cellular response to platelet-derived growth factor stimulus,GO:0036120,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CCL2
cellular response to reactive oxygen species,GO:0034614,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,MMP3
cellular response to retinoic acid,GO:0071300,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
cellular response to retinoic acid,GO:0071300,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CCL2
cellular response to rotenone,GO:1904648,Tuberculosis,MESH:D014376,1,Rifampin,0,
cellular response to rotenone,GO:1904648,"Tuberculosis, Central Nervous System",MESH:D020306,1,Rifampin,0,
cellular response to rotenone,GO:1904648,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Rifampin,0,
cellular response to rotenone,GO:1904648,"Tuberculosis, Lymph Node",MESH:D014388,1,Rifampin,0,
cellular response to rotenone,GO:1904648,"Tuberculosis, Meningeal",MESH:D014390,1,Rifampin,0,
cellular response to rotenone,GO:1904648,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Rifampin,0,
cellular response to rotenone,GO:1904648,"Tuberculosis, Pleural",MESH:D014396,1,Rifampin,0,
cellular response to rotenone,GO:1904648,"Tuberculosis, Pulmonary",MESH:D014397,1,Rifampin,0,
cellular response to rotenone,GO:1904648,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
cellular response to rotenone,GO:1904648,"Tuberculosis, Spinal",MESH:D014399,1,Rifampin,0,
cellular response to sodium arsenite,GO:1903936,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
cellular response to triacyl bacterial lipopeptide,GO:0071727,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,TLR2
cellular response to tumor necrosis factor,GO:0071356,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
cellular response to tumor necrosis factor,GO:0071356,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CCL2
cellular response to type II interferon,GO:0071346,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,3,CCL2|IRGM|TLR2
cellular response to type II interferon,GO:0071346,Paratuberculosis,MESH:D010283,0,,1,GSN
cellular response to type II interferon,GO:0071346,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CCL2
cellular response to unfolded protein,GO:0034620,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
cellular response to unfolded protein,GO:0034620,Tuberculosis,MESH:D014376,1,Gentamicins,0,
cellular response to unfolded protein,GO:0034620,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
cellular response to UV-A,GO:0071492,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,MMP3
cellular response to virus,GO:0098586,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,3,IFNG|IFNGR1|IRGM
cellular response to xenobiotic stimulus,GO:0071466,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
cellular response to xenobiotic stimulus,GO:0071466,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
cellular response to xenobiotic stimulus,GO:0071466,Tuberculosis,MESH:D014376,1,Verapamil,0,
cellular response to xenobiotic stimulus,GO:0071466,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,1,CCL2
cellular senescence,GO:0090398,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
cellular senescence,GO:0090398,Tuberculosis,MESH:D014376,1,Vitamin K 2,0,
cellular senescence,GO:0090398,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
cell volume homeostasis,GO:0006884,Tuberculosis,MESH:D014376,1,Iron,0,
central nervous system development,GO:0007417,Paratuberculosis,MESH:D010283,0,,1,GSN
central nervous system myelination,GO:0022010,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
central nervous system myelination,GO:0022010,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
central nervous system myelin formation,GO:0032289,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,TLR2
central nervous system projection neuron axonogenesis,GO:0021952,Tuberculosis,MESH:D014376,0,,1,CORO1A
ceramide biosynthetic process,GO:0046513,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
ceramide biosynthetic process,GO:0046513,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
cerebral cortex GABAergic interneuron migration,GO:0021853,"Tuberculosis, Pulmonary",MESH:D014397,1,Carbon Monoxide,0,
cGMP biosynthetic process,GO:0006182,"Tuberculosis, Pulmonary",MESH:D014397,1,Carbon Monoxide,0,
cGMP metabolic process,GO:0046068,"Tuberculosis, Pulmonary",MESH:D014397,1,Sulfur Dioxide,0,
chemokine (C-C motif) ligand 2 signaling pathway,GO:0038148,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
chemokine (C-C motif) ligand 2 signaling pathway,GO:0038148,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CCL2
chemokine-mediated signaling pathway,GO:0070098,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
chemokine-mediated signaling pathway,GO:0070098,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CCL2
chemokine production,GO:0032602,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,TLR2
chemokinesis,GO:0042466,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
chemokinesis,GO:0042466,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CCL2
chemotaxis,GO:0006935,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
chemotaxis,GO:0006935,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
chemotaxis,GO:0006935,Paratuberculosis,MESH:D010283,0,,1,C3
chemotaxis,GO:0006935,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,1,CCL2
chloride ion homeostasis,GO:0055064,Tuberculosis,MESH:D014376,1,Ciprofloxacin,0,
chloride ion homeostasis,GO:0055064,"Tuberculosis, Spinal",MESH:D014399,1,Ciprofloxacin,0,
chloride transmembrane transport,GO:1902476,Tuberculosis,MESH:D014376,1,Verapamil,0,
cholesterol biosynthetic process,GO:0006695,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
cholesterol biosynthetic process,GO:0006695,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
cholesterol biosynthetic process,GO:0006695,Tuberculosis,MESH:D014376,2,Chenodeoxycholic Acid|Isoniazid,0,
cholesterol biosynthetic process,GO:0006695,"Tuberculosis, Central Nervous System",MESH:D020306,1,Isoniazid,0,
cholesterol biosynthetic process,GO:0006695,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Isoniazid,0,
cholesterol biosynthetic process,GO:0006695,"Tuberculosis, Lymph Node",MESH:D014388,1,Isoniazid,0,
cholesterol biosynthetic process,GO:0006695,"Tuberculosis, Meningeal",MESH:D014390,1,Isoniazid,0,
cholesterol biosynthetic process,GO:0006695,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Isoniazid,0,
cholesterol biosynthetic process,GO:0006695,"Tuberculosis, Pleural",MESH:D014396,1,Isoniazid,0,
cholesterol biosynthetic process,GO:0006695,"Tuberculosis, Pulmonary",MESH:D014397,2,Isoniazid|Particulate Matter,0,
cholesterol biosynthetic process,GO:0006695,"Tuberculosis, Spinal",MESH:D014399,1,Isoniazid,0,
cholesterol homeostasis,GO:0042632,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
cholesterol homeostasis,GO:0042632,Tuberculosis,MESH:D014376,2,Pyrazinamide|Tretinoin,0,
cholesterol homeostasis,GO:0042632,"Tuberculosis, Central Nervous System",MESH:D020306,1,Pyrazinamide,0,
cholesterol homeostasis,GO:0042632,"Tuberculosis, Lymph Node",MESH:D014388,1,Pyrazinamide,0,
cholesterol homeostasis,GO:0042632,"Tuberculosis, Meningeal",MESH:D014390,1,Pyrazinamide,0,
cholesterol homeostasis,GO:0042632,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Pyrazinamide,0,
cholesterol homeostasis,GO:0042632,"Tuberculosis, Pulmonary",MESH:D014397,3,Air Pollutants|Particulate Matter|Pyrazinamide,0,
cholesterol homeostasis,GO:0042632,"Tuberculosis, Spinal",MESH:D014399,1,Pyrazinamide,0,
cholesterol metabolic process,GO:0008203,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
cholesterol metabolic process,GO:0008203,Tuberculosis,MESH:D014376,3,Chenodeoxycholic Acid|Iron|Tretinoin,0,
cholesterol metabolic process,GO:0008203,"Tuberculosis, Bovine",MESH:D014380,0,,1,IL4
cholesterol metabolic process,GO:0008203,"Tuberculosis, Pulmonary",MESH:D014397,3,Air Pollutants|Arsenic|Particulate Matter,0,
choline metabolic process,GO:0019695,Tuberculosis,MESH:D014376,1,Pyrazinamide,0,
choline metabolic process,GO:0019695,"Tuberculosis, Central Nervous System",MESH:D020306,1,Pyrazinamide,0,
choline metabolic process,GO:0019695,"Tuberculosis, Lymph Node",MESH:D014388,1,Pyrazinamide,0,
choline metabolic process,GO:0019695,"Tuberculosis, Meningeal",MESH:D014390,1,Pyrazinamide,0,
choline metabolic process,GO:0019695,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Pyrazinamide,0,
choline metabolic process,GO:0019695,"Tuberculosis, Pulmonary",MESH:D014397,1,Pyrazinamide,0,
choline metabolic process,GO:0019695,"Tuberculosis, Spinal",MESH:D014399,1,Pyrazinamide,0,
chordate embryonic development,GO:0043009,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
chromatin remodeling,GO:0006338,Tuberculosis,MESH:D014376,1,Tretinoin,0,
chronic inflammatory response,GO:0002544,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
chronic inflammatory response,GO:0002544,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CCL2
cilium assembly,GO:0060271,Paratuberculosis,MESH:D010283,0,,1,GSN
cilium assembly,GO:0060271,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,ASAP1
circulatory system development,GO:0072359,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
circulatory system development,GO:0072359,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
citrate metabolic process,GO:0006101,Tuberculosis,MESH:D014376,1,Pyrazinamide,0,
citrate metabolic process,GO:0006101,"Tuberculosis, Central Nervous System",MESH:D020306,1,Pyrazinamide,0,
citrate metabolic process,GO:0006101,"Tuberculosis, Lymph Node",MESH:D014388,1,Pyrazinamide,0,
citrate metabolic process,GO:0006101,"Tuberculosis, Meningeal",MESH:D014390,1,Pyrazinamide,0,
citrate metabolic process,GO:0006101,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Pyrazinamide,0,
citrate metabolic process,GO:0006101,"Tuberculosis, Pulmonary",MESH:D014397,1,Pyrazinamide,0,
citrate metabolic process,GO:0006101,"Tuberculosis, Spinal",MESH:D014399,1,Pyrazinamide,0,
citrulline metabolic process,GO:0000052,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
citrulline metabolic process,GO:0000052,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
cobalamin metabolic process,GO:0009235,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
coenzyme A metabolic process,GO:0015936,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
coenzyme A metabolic process,GO:0015936,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
cognition,GO:0050890,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
cognition,GO:0050890,"Tuberculosis, Pulmonary",MESH:D014397,6,Air Pollutants|Arsenic|Carbon Monoxide|Nitrogen Dioxide|Particulate Matter|Sulfur Dioxide,0,
cold-induced thermogenesis,GO:0106106,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
collagen biosynthetic process,GO:0032964,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
collagen biosynthetic process,GO:0032964,Tuberculosis,MESH:D014376,1,Prednisolone,0,
collagen biosynthetic process,GO:0032964,"Tuberculosis, Osteoarticular",MESH:D014394,1,Prednisolone,0,
collagen biosynthetic process,GO:0032964,"Tuberculosis, Pulmonary",MESH:D014397,2,Arsenic|Particulate Matter,0,
collagen catabolic process,GO:0030574,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
collagen catabolic process,GO:0030574,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,3,MMP3|MMP7|MMP8
collagen fibril organization,GO:0030199,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
collagen fibril organization,GO:0030199,Tuberculosis,MESH:D014376,1,Prednisolone,0,
collagen fibril organization,GO:0030199,"Tuberculosis, Osteoarticular",MESH:D014394,1,Prednisolone,0,
collagen fibril organization,GO:0030199,"Tuberculosis, Pulmonary",MESH:D014397,3,Air Pollutants|Arsenic|Particulate Matter,0,
collagen metabolic process,GO:0032963,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
collagen metabolic process,GO:0032963,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
complement activation,GO:0006956,Paratuberculosis,MESH:D010283,0,,2,C1R|C3
"complement activation, alternative pathway",GO:0006957,Paratuberculosis,MESH:D010283,0,,1,C3
"complement activation, classical pathway",GO:0006958,Paratuberculosis,MESH:D010283,0,,2,C1R|C3
complement-dependent cytotoxicity,GO:0097278,Paratuberculosis,MESH:D010283,0,,1,C3
complement-mediated synapse pruning,GO:0150062,Paratuberculosis,MESH:D010283,0,,1,C3
complement receptor mediated signaling pathway,GO:0002430,Paratuberculosis,MESH:D010283,0,,1,C3
corpus callosum development,GO:0022038,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
corpus callosum development,GO:0022038,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
corticosterone secretion,GO:0035934,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
creatine metabolic process,GO:0006600,Tuberculosis,MESH:D014376,2,Gentamicins|Pyrazinamide,0,
creatine metabolic process,GO:0006600,"Tuberculosis, Central Nervous System",MESH:D020306,1,Pyrazinamide,0,
creatine metabolic process,GO:0006600,"Tuberculosis, Lymph Node",MESH:D014388,1,Pyrazinamide,0,
creatine metabolic process,GO:0006600,"Tuberculosis, Meningeal",MESH:D014390,1,Pyrazinamide,0,
creatine metabolic process,GO:0006600,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Pyrazinamide,0,
creatine metabolic process,GO:0006600,"Tuberculosis, Pulmonary",MESH:D014397,1,Pyrazinamide,0,
creatine metabolic process,GO:0006600,"Tuberculosis, Spinal",MESH:D014399,1,Pyrazinamide,0,
creatinine metabolic process,GO:0046449,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
creatinine metabolic process,GO:0046449,Tuberculosis,MESH:D014376,4,Ciprofloxacin|Gentamicins|Ofloxacin|Verapamil,0,
creatinine metabolic process,GO:0046449,"Tuberculosis, Lymph Node",MESH:D014388,1,Ofloxacin,0,
creatinine metabolic process,GO:0046449,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Ofloxacin,0,
creatinine metabolic process,GO:0046449,"Tuberculosis, Osteoarticular",MESH:D014394,1,Ofloxacin,0,
creatinine metabolic process,GO:0046449,"Tuberculosis, Pulmonary",MESH:D014397,4,Air Pollutants|Arsenic|Ofloxacin|Particulate Matter,0,
creatinine metabolic process,GO:0046449,"Tuberculosis, Spinal",MESH:D014399,1,Ciprofloxacin,0,
cristae formation,GO:0042407,"Tuberculosis, Pulmonary",MESH:D014397,1,Sulfur Dioxide,0,
cytokine-mediated signaling pathway,GO:0019221,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,3,CCL2|CISH|IFNGR1
cytokine-mediated signaling pathway,GO:0019221,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
cytokine-mediated signaling pathway,GO:0019221,"Tuberculosis, Pulmonary",MESH:D014397,2,Nitrogen Dioxide|Particulate Matter,1,CCL2
cytokine production involved in immune response,GO:0002367,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
cytokine production involved in immune response,GO:0002367,"Tuberculosis, Pulmonary",MESH:D014397,4,Carbon Monoxide|Nitrogen Dioxide|Particulate Matter|Sulfur Dioxide,0,
cytokine production involved in inflammatory response,GO:0002534,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
cytokine production involved in inflammatory response,GO:0002534,Tuberculosis,MESH:D014376,1,Iron,0,
cytokine production involved in inflammatory response,GO:0002534,"Tuberculosis, Pulmonary",MESH:D014397,3,Air Pollutants|Arsenic|Particulate Matter,0,
cytolysis by host of symbiont cells,GO:0051838,Paratuberculosis,MESH:D010283,0,,1,F2
cytosine metabolic process,GO:0019858,Tuberculosis,MESH:D014376,1,Tretinoin,0,
"cytoskeletal rearrangement involved in phagocytosis, engulfment",GO:0060097,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
"cytoskeletal rearrangement involved in phagocytosis, engulfment",GO:0060097,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
cytoskeleton organization,GO:0007010,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
cytoskeleton organization,GO:0007010,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CCL2
defecation rhythm,GO:0035882,Tuberculosis,MESH:D014376,1,Verapamil,0,
defense response,GO:0006952,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,2,IRGM|TLR2
defense response,GO:0006952,Tuberculosis,MESH:D014376,0,,1,HP
defense response to bacterium,GO:0042742,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,3,IFNG|IRGM|SLC11A1
defense response to bacterium,GO:0042742,Tuberculosis,MESH:D014376,0,,2,HP|SLC11A1
defense response to bacterium,GO:0042742,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,1,MMP7
defense response to Gram-negative bacterium,GO:0050829,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,2,IRGM|SLC11A1
defense response to Gram-negative bacterium,GO:0050829,Tuberculosis,MESH:D014376,0,,1,SLC11A1
defense response to Gram-negative bacterium,GO:0050829,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,MMP7
defense response to Gram-positive bacterium,GO:0050830,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,3,IFNG|TIRAP|TLR2
defense response to Gram-positive bacterium,GO:0050830,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,1,TNFSF8
defense response to Gram-positive bacterium,GO:0050830,Tuberculosis,MESH:D014376,0,,1,TIRAP
defense response to Gram-positive bacterium,GO:0050830,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,1,MMP7
defense response to protozoan,GO:0042832,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,2,IFNG|SLC11A1
defense response to protozoan,GO:0042832,Tuberculosis,MESH:D014376,0,,1,SLC11A1
defense response to protozoan,GO:0042832,"Tuberculosis, Bovine",MESH:D014380,0,,1,IL4
defense response to virus,GO:0051607,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,3,IFNG|IFNGR1|TLR2
defense response to virus,GO:0051607,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
defense response to virus,GO:0051607,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
dendrite arborization,GO:0140059,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
dendrite arborization,GO:0140059,"Tuberculosis, Pulmonary",MESH:D014397,2,Arsenic|Particulate Matter,0,
dendrite extension,GO:0097484,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
dendrite extension,GO:0097484,Tuberculosis,MESH:D014376,1,Tretinoin,0,
dendrite extension,GO:0097484,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
dendritic cell antigen processing and presentation,GO:0002468,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CD209
dendritic cell antigen processing and presentation,GO:0002468,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CD209
dendritic cell differentiation,GO:0097028,"Tuberculosis, Bovine",MESH:D014380,0,,1,IL4
dendritic cell homeostasis,GO:0036145,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
dendritic cell migration,GO:0036336,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
dendritic cell migration,GO:0036336,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
dendritic spine morphogenesis,GO:0060997,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
dendritic spine morphogenesis,GO:0060997,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
deoxyguanosine metabolic process,GO:0042453,Tuberculosis,MESH:D014376,1,Iron,0,
detection of diacyl bacterial lipopeptide,GO:0042496,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,TLR2
detection of mechanical stimulus involved in sensory perception of pain,GO:0050966,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
detection of oxidative stress,GO:0070994,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
detection of oxidative stress,GO:0070994,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
detection of oxidative stress,GO:0070994,Tuberculosis,MESH:D014376,4,Iron|Isoniazid|Rifampin|Verapamil,0,
detection of oxidative stress,GO:0070994,"Tuberculosis, Central Nervous System",MESH:D020306,2,Isoniazid|Rifampin,0,
detection of oxidative stress,GO:0070994,"Tuberculosis, Gastrointestinal",MESH:D014385,2,Isoniazid|Rifampin,0,
detection of oxidative stress,GO:0070994,"Tuberculosis, Lymph Node",MESH:D014388,2,Isoniazid|Rifampin,0,
detection of oxidative stress,GO:0070994,"Tuberculosis, Meningeal",MESH:D014390,2,Isoniazid|Rifampin,0,
detection of oxidative stress,GO:0070994,"Tuberculosis, Multidrug-Resistant",MESH:D018088,2,Isoniazid|Rifampin,0,
detection of oxidative stress,GO:0070994,"Tuberculosis, Pleural",MESH:D014396,2,Isoniazid|Rifampin,0,
detection of oxidative stress,GO:0070994,"Tuberculosis, Pulmonary",MESH:D014397,5,Air Pollutants|Arsenic|Isoniazid|Particulate Matter|Rifampin,0,
detection of oxidative stress,GO:0070994,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
detection of oxidative stress,GO:0070994,"Tuberculosis, Spinal",MESH:D014399,2,Isoniazid|Rifampin,0,
detection of temperature stimulus involved in sensory perception of pain,GO:0050965,"Tuberculosis, Pulmonary",MESH:D014397,1,Carbon Monoxide,0,
detection of triacyl bacterial lipopeptide,GO:0042495,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,TLR2
determination of adult lifespan,GO:0008340,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
determination of adult lifespan,GO:0008340,Tuberculosis,MESH:D014376,2,Ciprofloxacin|Ofloxacin,0,
determination of adult lifespan,GO:0008340,"Tuberculosis, Lymph Node",MESH:D014388,1,Ofloxacin,0,
determination of adult lifespan,GO:0008340,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Ofloxacin,0,
determination of adult lifespan,GO:0008340,"Tuberculosis, Osteoarticular",MESH:D014394,1,Ofloxacin,0,
determination of adult lifespan,GO:0008340,"Tuberculosis, Pulmonary",MESH:D014397,2,Ofloxacin|Particulate Matter,0,
determination of adult lifespan,GO:0008340,"Tuberculosis, Spinal",MESH:D014399,1,Ciprofloxacin,0,
determination of ventral identity,GO:0048264,Tuberculosis,MESH:D014376,1,Tretinoin,0,
detoxification of arsenic-containing substance,GO:0071722,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
developmental growth,GO:0048589,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
developmental process,GO:0032502,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
developmental process,GO:0032502,Paratuberculosis,MESH:D010283,0,,1,C1R
developmental process,GO:0032502,Tuberculosis,MESH:D014376,4,Ciprofloxacin|Ofloxacin|Tretinoin|Verapamil,0,
developmental process,GO:0032502,"Tuberculosis, Lymph Node",MESH:D014388,1,Ofloxacin,0,
developmental process,GO:0032502,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Ofloxacin,0,
developmental process,GO:0032502,"Tuberculosis, Osteoarticular",MESH:D014394,1,Ofloxacin,0,
developmental process,GO:0032502,"Tuberculosis, Pulmonary",MESH:D014397,3,Air Pollutants|Ofloxacin|Particulate Matter,0,
developmental process,GO:0032502,"Tuberculosis, Spinal",MESH:D014399,1,Ciprofloxacin,0,
DNA biosynthetic process,GO:0071897,Tuberculosis,MESH:D014376,2,Gentamicins|Tretinoin,0,
DNA biosynthetic process,GO:0071897,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
DNA catabolic process,GO:0006308,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
DNA catabolic process,GO:0006308,"Tuberculosis, Pulmonary",MESH:D014397,2,Arsenic|Particulate Matter,0,
"DNA catabolic process, endonucleolytic",GO:0000737,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
"DNA catabolic process, endonucleolytic",GO:0000737,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
"DNA catabolic process, endonucleolytic",GO:0000737,Tuberculosis,MESH:D014376,2,Iron|Isoniazid,0,
"DNA catabolic process, endonucleolytic",GO:0000737,"Tuberculosis, Central Nervous System",MESH:D020306,1,Isoniazid,0,
"DNA catabolic process, endonucleolytic",GO:0000737,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Isoniazid,0,
"DNA catabolic process, endonucleolytic",GO:0000737,"Tuberculosis, Lymph Node",MESH:D014388,1,Isoniazid,0,
"DNA catabolic process, endonucleolytic",GO:0000737,"Tuberculosis, Meningeal",MESH:D014390,1,Isoniazid,0,
"DNA catabolic process, endonucleolytic",GO:0000737,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Isoniazid,0,
"DNA catabolic process, endonucleolytic",GO:0000737,"Tuberculosis, Pleural",MESH:D014396,1,Isoniazid,0,
"DNA catabolic process, endonucleolytic",GO:0000737,"Tuberculosis, Pulmonary",MESH:D014397,3,Arsenic|Isoniazid|Particulate Matter,0,
"DNA catabolic process, endonucleolytic",GO:0000737,"Tuberculosis, Spinal",MESH:D014399,1,Isoniazid,0,
DNA hypermethylation,GO:0044026,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
DNA hypomethylation,GO:0044028,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
DNA hypomethylation,GO:0044028,"Tuberculosis, Pulmonary",MESH:D014397,2,Arsenic|Particulate Matter,0,
DNA metabolic process,GO:0006259,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
DNA metabolic process,GO:0006259,Tuberculosis,MESH:D014376,1,Isoniazid,0,
DNA metabolic process,GO:0006259,"Tuberculosis, Central Nervous System",MESH:D020306,1,Isoniazid,0,
DNA metabolic process,GO:0006259,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Isoniazid,0,
DNA metabolic process,GO:0006259,"Tuberculosis, Lymph Node",MESH:D014388,1,Isoniazid,0,
DNA metabolic process,GO:0006259,"Tuberculosis, Meningeal",MESH:D014390,1,Isoniazid,0,
DNA metabolic process,GO:0006259,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Isoniazid,0,
DNA metabolic process,GO:0006259,"Tuberculosis, Pleural",MESH:D014396,1,Isoniazid,0,
DNA metabolic process,GO:0006259,"Tuberculosis, Pulmonary",MESH:D014397,1,Isoniazid,0,
DNA metabolic process,GO:0006259,"Tuberculosis, Spinal",MESH:D014399,1,Isoniazid,0,
DNA methylation,GO:0006306,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
DNA methylation,GO:0006306,Tuberculosis,MESH:D014376,1,Tretinoin,0,
DNA methylation,GO:0006306,"Tuberculosis, Pulmonary",MESH:D014397,5,Air Pollutants|Arsenic|Carbon Monoxide|Nitrogen Dioxide|Particulate Matter,0,
DNA methylation involved in embryo development,GO:0043045,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
DNA methylation on cytosine within a CG sequence,GO:0010424,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
DNA methylation on cytosine within a CG sequence,GO:0010424,"Tuberculosis, Pulmonary",MESH:D014397,4,Air Pollutants|Arsenic|Nitrogen Dioxide|Particulate Matter,0,
DNA modification,GO:0006304,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
DNA modification,GO:0006304,Tuberculosis,MESH:D014376,2,Iron|Tretinoin,0,
DNA modification,GO:0006304,"Tuberculosis, Pulmonary",MESH:D014397,3,Air Pollutants|Arsenic|Particulate Matter,0,
DNA repair,GO:0006281,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
DNA repair,GO:0006281,"Tuberculosis, Pulmonary",MESH:D014397,2,Arsenic|Particulate Matter,0,
DNA replication,GO:0006260,Tuberculosis,MESH:D014376,1,Vitamin K 2,0,
DNA replication,GO:0006260,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
DNA transport,GO:0051027,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
dopamine metabolic process,GO:0042417,Extensively Drug-Resistant Tuberculosis,MESH:D054908,1,Tolcapone,0,
dopamine metabolic process,GO:0042417,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
dopamine metabolic process,GO:0042417,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Tolcapone,0,
dopamine metabolic process,GO:0042417,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
dopaminergic neuron differentiation,GO:0071542,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
dopaminergic neuron differentiation,GO:0071542,Tuberculosis,MESH:D014376,1,Tretinoin,0,
dopaminergic neuron differentiation,GO:0071542,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
dopamine secretion,GO:0014046,Tuberculosis,MESH:D014376,1,Iron,0,
doxorubicin transport,GO:1900753,Tuberculosis,MESH:D014376,1,Verapamil,0,
drinking behavior,GO:0042756,"Tuberculosis, Pulmonary",MESH:D014397,2,Arsenic|Sulfur Dioxide,0,
early endosome to recycling endosome transport,GO:0061502,Tuberculosis,MESH:D014376,0,,1,CORO1A
eating behavior,GO:0042755,Paratuberculosis,MESH:D010283,0,,1,AOC3
eating behavior,GO:0042755,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
eggshell formation,GO:0030703,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
electron transport chain,GO:0022900,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
electron transport chain,GO:0022900,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
embryo development,GO:0009790,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
embryo development,GO:0009790,Tuberculosis,MESH:D014376,2,Tretinoin|Verapamil,0,
embryo development,GO:0009790,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
embryonic brain development,GO:1990403,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
embryonic brain development,GO:1990403,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
embryonic cleavage,GO:0040016,Tuberculosis,MESH:D014376,1,Verapamil,0,
embryonic digestive tract development,GO:0048566,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
embryonic digestive tract development,GO:0048566,Tuberculosis,MESH:D014376,1,Isoniazid,0,
embryonic digestive tract development,GO:0048566,"Tuberculosis, Central Nervous System",MESH:D020306,1,Isoniazid,0,
embryonic digestive tract development,GO:0048566,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Isoniazid,0,
embryonic digestive tract development,GO:0048566,"Tuberculosis, Lymph Node",MESH:D014388,1,Isoniazid,0,
embryonic digestive tract development,GO:0048566,"Tuberculosis, Meningeal",MESH:D014390,1,Isoniazid,0,
embryonic digestive tract development,GO:0048566,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Isoniazid,0,
embryonic digestive tract development,GO:0048566,"Tuberculosis, Pleural",MESH:D014396,1,Isoniazid,0,
embryonic digestive tract development,GO:0048566,"Tuberculosis, Pulmonary",MESH:D014397,1,Isoniazid,0,
embryonic digestive tract development,GO:0048566,"Tuberculosis, Spinal",MESH:D014399,1,Isoniazid,0,
embryonic placenta development,GO:0001892,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
embryonic placenta development,GO:0001892,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
embryonic placenta morphogenesis,GO:0060669,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
embryonic placenta morphogenesis,GO:0060669,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
endocytosis,GO:0006897,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CD209
endocytosis,GO:0006897,Tuberculosis,MESH:D014376,1,Prednisolone,0,
endocytosis,GO:0006897,"Tuberculosis, Osteoarticular",MESH:D014394,1,Prednisolone,0,
endocytosis,GO:0006897,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CD209
endodermal cell differentiation,GO:0035987,Tuberculosis,MESH:D014376,1,Tretinoin,0,
endodermal cell differentiation,GO:0035987,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,MMP8
endoplasmic reticulum disassembly,GO:1905692,Tuberculosis,MESH:D014376,2,Ciprofloxacin|Ofloxacin,0,
endoplasmic reticulum disassembly,GO:1905692,"Tuberculosis, Lymph Node",MESH:D014388,1,Ofloxacin,0,
endoplasmic reticulum disassembly,GO:1905692,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Ofloxacin,0,
endoplasmic reticulum disassembly,GO:1905692,"Tuberculosis, Osteoarticular",MESH:D014394,1,Ofloxacin,0,
endoplasmic reticulum disassembly,GO:1905692,"Tuberculosis, Pulmonary",MESH:D014397,1,Ofloxacin,0,
endoplasmic reticulum disassembly,GO:1905692,"Tuberculosis, Spinal",MESH:D014399,1,Ciprofloxacin,0,
endoplasmic reticulum organization,GO:0007029,"Tuberculosis, Pulmonary",MESH:D014397,1,Carbon Monoxide,0,
endoplasmic reticulum unfolded protein response,GO:0030968,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,IFNG
endosomal lumen acidification,GO:0048388,Tuberculosis,MESH:D014376,1,Iron,0,
endothelial cell-cell adhesion,GO:0071603,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
endothelial cell-cell adhesion,GO:0071603,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
endothelial to hematopoietic transition,GO:0098508,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,IFNGR1
endothelial tube lumen extension involved in blood vessel lumen ensheathment,GO:1902355,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
endothelial tube lumen extension involved in blood vessel lumen ensheathment,GO:1902355,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
endothelin receptor signaling pathway,GO:0086100,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
endothelin receptor signaling pathway,GO:0086100,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
energy homeostasis,GO:0097009,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Air Pollutants,0,
energy homeostasis,GO:0097009,"Tuberculosis, Pulmonary",MESH:D014397,1,Air Pollutants,0,
energy reserve metabolic process,GO:0006112,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
energy reserve metabolic process,GO:0006112,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
eosinophil activation involved in immune response,GO:0002278,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
eosinophil activation involved in immune response,GO:0002278,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
eosinophil chemotaxis,GO:0048245,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
eosinophil chemotaxis,GO:0048245,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CCL2
eosinophil extravasation,GO:0072682,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
eosinophil extravasation,GO:0072682,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
eosinophil homeostasis,GO:1990959,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
eosinophil homeostasis,GO:1990959,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
eosinophil migration,GO:0072677,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
eosinophil migration,GO:0072677,"Tuberculosis, Pulmonary",MESH:D014397,3,Air Pollutants|Particulate Matter|Sulfur Dioxide,0,
epididymis development,GO:1905867,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
epigenetic regulation of gene expression,GO:0040029,Tuberculosis,MESH:D014376,1,Tretinoin,0,
epigenetic regulation of gene expression,GO:0040029,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
epinephrine metabolic process,GO:0042414,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
epinephrine metabolic process,GO:0042414,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
epithelial cell migration,GO:0010631,Tuberculosis,MESH:D014376,0,,1,CORO1A
epithelial to mesenchymal transition,GO:0001837,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
epithelial to mesenchymal transition,GO:0001837,"Tuberculosis, Pulmonary",MESH:D014397,3,Air Pollutants|Arsenic|Particulate Matter,0,
epoxygenase P450 pathway,GO:0019373,Tuberculosis,MESH:D014376,1,Verapamil,0,
ERK1 and ERK2 cascade,GO:0070371,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,TLR2
ERK1 and ERK2 cascade,GO:0070371,Paratuberculosis,MESH:D010283,0,,1,TF
erythrocyte aggregation,GO:0034117,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
erythrocyte aggregation,GO:0034117,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
erythrocyte differentiation,GO:0030218,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
erythrocyte homeostasis,GO:0034101,Tuberculosis,MESH:D014376,1,Iron,0,
establishment of blood-nerve barrier,GO:0008065,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
establishment of cell polarity,GO:0030010,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
establishment of cell polarity,GO:0030010,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
establishment of endothelial intestinal barrier,GO:0090557,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
establishment of endothelial intestinal barrier,GO:0090557,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
establishment of localization in cell,GO:0051649,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,SLC11A1
establishment of localization in cell,GO:0051649,Tuberculosis,MESH:D014376,0,,2,CORO1A|SLC11A1
establishment of protein localization to plasma membrane,GO:0061951,"Tuberculosis, Meningeal",MESH:D014390,1,Methylprednisolone Acetate,0,
estrogen metabolic process,GO:0008210,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
estrogen secretion,GO:0035937,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
estrous cycle,GO:0044849,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,MMP7
exocytosis,GO:0006887,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
exosomal secretion,GO:1990182,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
exosomal secretion,GO:1990182,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
exploration behavior,GO:0035640,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
exploration behavior,GO:0035640,"Tuberculosis, Pulmonary",MESH:D014397,3,Air Pollutants|Arsenic|Particulate Matter,0,
export across plasma membrane,GO:0140115,Tuberculosis,MESH:D014376,1,Verapamil,0,
extracellular matrix disassembly,GO:0022617,"Tuberculosis, Pulmonary",MESH:D014397,0,,3,MMP3|MMP7|MMP8
extracellular matrix organization,GO:0030198,"Tuberculosis, Pulmonary",MESH:D014397,0,,3,MMP3|MMP7|MMP8
extraembryonic membrane development,GO:1903867,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
extraembryonic membrane development,GO:1903867,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
extrinsic apoptotic signaling pathway,GO:0097191,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,IFNG
extrinsic apoptotic signaling pathway,GO:0097191,"Tuberculosis, Bovine",MESH:D014380,0,,1,IL4
extrinsic apoptotic signaling pathway in absence of ligand,GO:0097192,"Tuberculosis, Bovine",MESH:D014380,0,,1,IL4
eye development,GO:0001654,Tuberculosis,MESH:D014376,1,Tretinoin,1,CORO1A
face development,GO:0060324,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
face development,GO:0060324,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
fat cell differentiation,GO:0045444,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
fat cell differentiation,GO:0045444,Tuberculosis,MESH:D014376,2,Isoniazid|Tretinoin,0,
fat cell differentiation,GO:0045444,"Tuberculosis, Central Nervous System",MESH:D020306,1,Isoniazid,0,
fat cell differentiation,GO:0045444,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Isoniazid,0,
fat cell differentiation,GO:0045444,"Tuberculosis, Lymph Node",MESH:D014388,1,Isoniazid,0,
fat cell differentiation,GO:0045444,"Tuberculosis, Meningeal",MESH:D014390,1,Isoniazid,0,
fat cell differentiation,GO:0045444,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Isoniazid,0,
fat cell differentiation,GO:0045444,"Tuberculosis, Pleural",MESH:D014396,1,Isoniazid,0,
fat cell differentiation,GO:0045444,"Tuberculosis, Pulmonary",MESH:D014397,2,Arsenic|Isoniazid,0,
fat cell differentiation,GO:0045444,"Tuberculosis, Spinal",MESH:D014399,1,Isoniazid,0,
fat cell proliferation,GO:0070341,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
fat cell proliferation,GO:0070341,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
fat pad development,GO:0060613,Tuberculosis,MESH:D014376,1,Rifampin,0,
fat pad development,GO:0060613,"Tuberculosis, Central Nervous System",MESH:D020306,1,Rifampin,0,
fat pad development,GO:0060613,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Rifampin,0,
fat pad development,GO:0060613,"Tuberculosis, Lymph Node",MESH:D014388,1,Rifampin,0,
fat pad development,GO:0060613,"Tuberculosis, Meningeal",MESH:D014390,1,Rifampin,0,
fat pad development,GO:0060613,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Rifampin,0,
fat pad development,GO:0060613,"Tuberculosis, Pleural",MESH:D014396,1,Rifampin,0,
fat pad development,GO:0060613,"Tuberculosis, Pulmonary",MESH:D014397,1,Rifampin,0,
fat pad development,GO:0060613,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
fat pad development,GO:0060613,"Tuberculosis, Spinal",MESH:D014399,1,Rifampin,0,
fatty acid biosynthetic process,GO:0006633,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
fatty acid biosynthetic process,GO:0006633,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
fatty acid catabolic process,GO:0009062,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Air Pollutants,0,
fatty acid catabolic process,GO:0009062,"Tuberculosis, Pulmonary",MESH:D014397,1,Air Pollutants,0,
fatty acid metabolic process,GO:0006631,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
fatty acid metabolic process,GO:0006631,Paratuberculosis,MESH:D010283,0,,1,C3
fatty acid metabolic process,GO:0006631,Tuberculosis,MESH:D014376,2,Chenodeoxycholic Acid|Tretinoin,0,
fatty acid metabolic process,GO:0006631,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
fatty acid oxidation,GO:0019395,Tuberculosis,MESH:D014376,1,Rifampin,0,
fatty acid oxidation,GO:0019395,"Tuberculosis, Central Nervous System",MESH:D020306,1,Rifampin,0,
fatty acid oxidation,GO:0019395,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Rifampin,0,
fatty acid oxidation,GO:0019395,"Tuberculosis, Lymph Node",MESH:D014388,1,Rifampin,0,
fatty acid oxidation,GO:0019395,"Tuberculosis, Meningeal",MESH:D014390,1,Rifampin,0,
fatty acid oxidation,GO:0019395,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Rifampin,0,
fatty acid oxidation,GO:0019395,"Tuberculosis, Pleural",MESH:D014396,1,Rifampin,0,
fatty acid oxidation,GO:0019395,"Tuberculosis, Pulmonary",MESH:D014397,1,Rifampin,0,
fatty acid oxidation,GO:0019395,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
fatty acid oxidation,GO:0019395,"Tuberculosis, Spinal",MESH:D014399,1,Rifampin,0,
Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0038096,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,IFNG
Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0038096,Tuberculosis,MESH:D014376,1,Iron,0,
feeding behavior,GO:0007631,"Tuberculosis, Pulmonary",MESH:D014397,2,Arsenic|Sulfur Dioxide,0,
female pregnancy,GO:0007565,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Air Pollutants,0,
female pregnancy,GO:0007565,"Tuberculosis, Bovine",MESH:D014380,0,,1,IL4
female pregnancy,GO:0007565,"Tuberculosis, Pulmonary",MESH:D014397,1,Air Pollutants,1,MMP3
ferroptosis,GO:0097707,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
ferroptosis,GO:0097707,Tuberculosis,MESH:D014376,1,Iron,0,
ferroptosis,GO:0097707,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
fertilization,GO:0009566,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
fertilization,GO:0009566,Tuberculosis,MESH:D014376,1,Isoniazid,0,
fertilization,GO:0009566,"Tuberculosis, Central Nervous System",MESH:D020306,1,Isoniazid,0,
fertilization,GO:0009566,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Isoniazid,0,
fertilization,GO:0009566,"Tuberculosis, Lymph Node",MESH:D014388,1,Isoniazid,0,
fertilization,GO:0009566,"Tuberculosis, Meningeal",MESH:D014390,1,Isoniazid,0,
fertilization,GO:0009566,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Isoniazid,0,
fertilization,GO:0009566,"Tuberculosis, Pleural",MESH:D014396,1,Isoniazid,0,
fertilization,GO:0009566,"Tuberculosis, Pulmonary",MESH:D014397,1,Isoniazid,0,
fertilization,GO:0009566,"Tuberculosis, Spinal",MESH:D014399,1,Isoniazid,0,
fibrinolysis,GO:0042730,Paratuberculosis,MESH:D010283,0,,1,F2
fin development,GO:0033333,Tuberculosis,MESH:D014376,1,Tretinoin,0,
folic acid metabolic process,GO:0046655,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
follicle-stimulating hormone secretion,GO:0046884,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
follicle-stimulating hormone secretion,GO:0046884,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
G0 to G1 transition,GO:0045023,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
G2/M transition of mitotic cell cycle,GO:0000086,Tuberculosis,MESH:D014376,2,Ciprofloxacin|Tretinoin,0,
G2/M transition of mitotic cell cycle,GO:0000086,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
G2/M transition of mitotic cell cycle,GO:0000086,"Tuberculosis, Spinal",MESH:D014399,1,Ciprofloxacin,0,
gamma-aminobutyric acid biosynthetic process,GO:0009449,Tuberculosis,MESH:D014376,1,Ciprofloxacin,0,
gamma-aminobutyric acid biosynthetic process,GO:0009449,"Tuberculosis, Spinal",MESH:D014399,1,Ciprofloxacin,0,
gene expression,GO:0010467,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
gene expression,GO:0010467,"Tuberculosis, Pulmonary",MESH:D014397,4,Air Pollutants|Arsenic|Nitrogen Dioxide|Particulate Matter,0,
germ cell development,GO:0007281,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
germ cell development,GO:0007281,Tuberculosis,MESH:D014376,1,Tretinoin,0,
germ cell development,GO:0007281,"Tuberculosis, Pulmonary",MESH:D014397,2,Arsenic|Particulate Matter,0,
glial cell activation,GO:0061900,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
glial cell activation,GO:0061900,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
glial cell growth,GO:0042065,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
glial cell growth,GO:0042065,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
glial cell migration,GO:0008347,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
glial cell migration,GO:0008347,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CCL2
glomerular filtration,GO:0003094,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
glomerular filtration,GO:0003094,Tuberculosis,MESH:D014376,2,Gentamicins|Tretinoin,0,
glomerular filtration,GO:0003094,"Tuberculosis, Pulmonary",MESH:D014397,2,Arsenic|Particulate Matter,0,
gluconeogenesis,GO:0006094,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Gatifloxacin,0,
glucose catabolic process,GO:0006007,Tuberculosis,MESH:D014376,1,Rifampin,0,
glucose catabolic process,GO:0006007,"Tuberculosis, Central Nervous System",MESH:D020306,1,Rifampin,0,
glucose catabolic process,GO:0006007,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Rifampin,0,
glucose catabolic process,GO:0006007,"Tuberculosis, Lymph Node",MESH:D014388,1,Rifampin,0,
glucose catabolic process,GO:0006007,"Tuberculosis, Meningeal",MESH:D014390,1,Rifampin,0,
glucose catabolic process,GO:0006007,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Rifampin,0,
glucose catabolic process,GO:0006007,"Tuberculosis, Pleural",MESH:D014396,1,Rifampin,0,
glucose catabolic process,GO:0006007,"Tuberculosis, Pulmonary",MESH:D014397,1,Rifampin,0,
glucose catabolic process,GO:0006007,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
glucose catabolic process,GO:0006007,"Tuberculosis, Spinal",MESH:D014399,1,Rifampin,0,
glucose homeostasis,GO:0042593,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
glucose homeostasis,GO:0042593,"Tuberculosis, Pulmonary",MESH:D014397,4,Air Pollutants|Arsenic|Nitrogen Dioxide|Particulate Matter,0,
glucose import,GO:0046323,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
glucose import,GO:0046323,"Tuberculosis, Pulmonary",MESH:D014397,3,Air Pollutants|Arsenic|Particulate Matter,0,
glucose import in response to insulin stimulus,GO:0044381,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
glucose metabolic process,GO:0006006,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
glucose metabolic process,GO:0006006,Tuberculosis,MESH:D014376,1,Pyrazinamide,0,
glucose metabolic process,GO:0006006,"Tuberculosis, Central Nervous System",MESH:D020306,1,Pyrazinamide,0,
glucose metabolic process,GO:0006006,"Tuberculosis, Lymph Node",MESH:D014388,1,Pyrazinamide,0,
glucose metabolic process,GO:0006006,"Tuberculosis, Meningeal",MESH:D014390,1,Pyrazinamide,0,
glucose metabolic process,GO:0006006,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Pyrazinamide,0,
glucose metabolic process,GO:0006006,"Tuberculosis, Pulmonary",MESH:D014397,6,Air Pollutants|Arsenic|Nitrogen Dioxide|Particulate Matter|Pyrazinamide|Sulfur Dioxide,0,
glucose metabolic process,GO:0006006,"Tuberculosis, Spinal",MESH:D014399,1,Pyrazinamide,0,
glutamate metabolic process,GO:0006536,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
glutamate metabolic process,GO:0006536,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
glutamine metabolic process,GO:0006541,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
glutamine metabolic process,GO:0006541,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
glutathione biosynthetic process,GO:0006750,Extensively Drug-Resistant Tuberculosis,MESH:D054908,1,Ethambutol,0,
glutathione biosynthetic process,GO:0006750,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
glutathione biosynthetic process,GO:0006750,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
glutathione biosynthetic process,GO:0006750,Tuberculosis,MESH:D014376,7,Ciprofloxacin|Ethambutol|Gentamicins|Iron|Isoniazid|Pyrazinamide|Rifampin,0,
glutathione biosynthetic process,GO:0006750,"Tuberculosis, Central Nervous System",MESH:D020306,4,Ethambutol|Isoniazid|Pyrazinamide|Rifampin,0,
glutathione biosynthetic process,GO:0006750,"Tuberculosis, Gastrointestinal",MESH:D014385,2,Isoniazid|Rifampin,0,
glutathione biosynthetic process,GO:0006750,"Tuberculosis, Lymph Node",MESH:D014388,4,Ethambutol|Isoniazid|Pyrazinamide|Rifampin,0,
glutathione biosynthetic process,GO:0006750,"Tuberculosis, Meningeal",MESH:D014390,3,Isoniazid|Pyrazinamide|Rifampin,0,
glutathione biosynthetic process,GO:0006750,"Tuberculosis, Miliary",MESH:D014391,1,Ethambutol,0,
glutathione biosynthetic process,GO:0006750,"Tuberculosis, Multidrug-Resistant",MESH:D018088,4,Ethambutol|Isoniazid|Pyrazinamide|Rifampin,0,
glutathione biosynthetic process,GO:0006750,"Tuberculosis, Osteoarticular",MESH:D014394,1,Ethambutol,0,
glutathione biosynthetic process,GO:0006750,"Tuberculosis, Pleural",MESH:D014396,3,Ethambutol|Isoniazid|Rifampin,0,
glutathione biosynthetic process,GO:0006750,"Tuberculosis, Pulmonary",MESH:D014397,7,Air Pollutants|Arsenic|Ethambutol|Isoniazid|Particulate Matter|Pyrazinamide|Rifampin,0,
glutathione biosynthetic process,GO:0006750,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
glutathione biosynthetic process,GO:0006750,"Tuberculosis, Spinal",MESH:D014399,5,Ciprofloxacin|Ethambutol|Isoniazid|Pyrazinamide|Rifampin,0,
glutathione derivative biosynthetic process,GO:1901687,"Tuberculosis, Pulmonary",MESH:D014397,2,Arsenic|Sulfur Dioxide,0,
glutathione metabolic process,GO:0006749,Extensively Drug-Resistant Tuberculosis,MESH:D054908,1,Ethambutol,0,
glutathione metabolic process,GO:0006749,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
glutathione metabolic process,GO:0006749,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
glutathione metabolic process,GO:0006749,Tuberculosis,MESH:D014376,10,"Ciprofloxacin|Ethambutol|Gentamicins|Iron|Isoniazid|isoniazid, pyrazinamide, rifampin drug combination|Pyrazinamide|Rifampin|Tretinoin|Verapamil",0,
glutathione metabolic process,GO:0006749,"Tuberculosis, Central Nervous System",MESH:D020306,4,Ethambutol|Isoniazid|Pyrazinamide|Rifampin,0,
glutathione metabolic process,GO:0006749,"Tuberculosis, Gastrointestinal",MESH:D014385,2,Isoniazid|Rifampin,0,
glutathione metabolic process,GO:0006749,"Tuberculosis, Lymph Node",MESH:D014388,5,"Ethambutol|Isoniazid|isoniazid, pyrazinamide, rifampin drug combination|Pyrazinamide|Rifampin",0,
glutathione metabolic process,GO:0006749,"Tuberculosis, Meningeal",MESH:D014390,3,Isoniazid|Pyrazinamide|Rifampin,0,
glutathione metabolic process,GO:0006749,"Tuberculosis, Miliary",MESH:D014391,2,"Ethambutol|isoniazid, pyrazinamide, rifampin drug combination",0,
glutathione metabolic process,GO:0006749,"Tuberculosis, Multidrug-Resistant",MESH:D018088,4,Ethambutol|Isoniazid|Pyrazinamide|Rifampin,0,
glutathione metabolic process,GO:0006749,"Tuberculosis, Osteoarticular",MESH:D014394,2,"Ethambutol|isoniazid, pyrazinamide, rifampin drug combination",0,
glutathione metabolic process,GO:0006749,"Tuberculosis, Pleural",MESH:D014396,3,Ethambutol|Isoniazid|Rifampin,0,
glutathione metabolic process,GO:0006749,"Tuberculosis, Pulmonary",MESH:D014397,9,"Air Pollutants|Arsenic|Ethambutol|Isoniazid|isoniazid, pyrazinamide, rifampin drug combination|Particulate Matter|Pyrazinamide|Rifampin|Sulfur Dioxide",0,
glutathione metabolic process,GO:0006749,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
glutathione metabolic process,GO:0006749,"Tuberculosis, Spinal",MESH:D014399,5,Ciprofloxacin|Ethambutol|Isoniazid|Pyrazinamide|Rifampin,0,
glycerol metabolic process,GO:0006071,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
glycerophospholipid metabolic process,GO:0006650,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
glycerophospholipid metabolic process,GO:0006650,"Tuberculosis, Pulmonary",MESH:D014397,3,Air Pollutants|Clarithromycin|Particulate Matter,0,
glycine metabolic process,GO:0006544,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
glycogen metabolic process,GO:0005977,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
glycogen metabolic process,GO:0005977,"Tuberculosis, Pulmonary",MESH:D014397,3,Air Pollutants|Arsenic|Particulate Matter,0,
glycolytic process,GO:0006096,Tuberculosis,MESH:D014376,1,Tretinoin,0,
glycolytic process,GO:0006096,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
glycoprotein metabolic process,GO:0009100,Tuberculosis,MESH:D014376,1,Pyrazinamide,0,
glycoprotein metabolic process,GO:0009100,"Tuberculosis, Central Nervous System",MESH:D020306,1,Pyrazinamide,0,
glycoprotein metabolic process,GO:0009100,"Tuberculosis, Lymph Node",MESH:D014388,1,Pyrazinamide,0,
glycoprotein metabolic process,GO:0009100,"Tuberculosis, Meningeal",MESH:D014390,1,Pyrazinamide,0,
glycoprotein metabolic process,GO:0009100,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Pyrazinamide,0,
glycoprotein metabolic process,GO:0009100,"Tuberculosis, Pulmonary",MESH:D014397,1,Pyrazinamide,0,
glycoprotein metabolic process,GO:0009100,"Tuberculosis, Spinal",MESH:D014399,1,Pyrazinamide,0,
Golgi to plasma membrane protein transport,GO:0043001,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,ASAP1
G protein-coupled receptor signaling pathway,GO:0007186,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
G protein-coupled receptor signaling pathway,GO:0007186,Paratuberculosis,MESH:D010283,0,,2,C3|F2
G protein-coupled receptor signaling pathway,GO:0007186,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CCL2
"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger",GO:0007187,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger",GO:0007187,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CCL2
granulocyte activation,GO:0036230,Tuberculosis,MESH:D014376,1,Tretinoin,0,
granulocyte differentiation,GO:0030851,Tuberculosis,MESH:D014376,1,Tretinoin,0,
gravitaxis,GO:0042332,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
hatching,GO:0035188,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
hatching,GO:0035188,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
hatching,GO:0035188,Tuberculosis,MESH:D014376,4,Ciprofloxacin|Isoniazid|Ofloxacin|Tretinoin,0,
hatching,GO:0035188,"Tuberculosis, Central Nervous System",MESH:D020306,1,Isoniazid,0,
hatching,GO:0035188,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Isoniazid,0,
hatching,GO:0035188,"Tuberculosis, Lymph Node",MESH:D014388,2,Isoniazid|Ofloxacin,0,
hatching,GO:0035188,"Tuberculosis, Meningeal",MESH:D014390,1,Isoniazid,0,
hatching,GO:0035188,"Tuberculosis, Multidrug-Resistant",MESH:D018088,2,Isoniazid|Ofloxacin,0,
hatching,GO:0035188,"Tuberculosis, Osteoarticular",MESH:D014394,1,Ofloxacin,0,
hatching,GO:0035188,"Tuberculosis, Pleural",MESH:D014396,1,Isoniazid,0,
hatching,GO:0035188,"Tuberculosis, Pulmonary",MESH:D014397,4,Air Pollutants|Isoniazid|Ofloxacin|Particulate Matter,0,
hatching,GO:0035188,"Tuberculosis, Spinal",MESH:D014399,2,Ciprofloxacin|Isoniazid,0,
head development,GO:0060322,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
head morphogenesis,GO:0060323,Tuberculosis,MESH:D014376,1,Tretinoin,0,
heart contraction,GO:0060047,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
heart contraction,GO:0060047,Tuberculosis,MESH:D014376,1,Verapamil,0,
heart contraction,GO:0060047,"Tuberculosis, Pulmonary",MESH:D014397,4,Air Pollutants|Arsenic|Nitrogen Dioxide|Particulate Matter,0,
heart development,GO:0007507,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
heart development,GO:0007507,"Tuberculosis, Pulmonary",MESH:D014397,3,Air Pollutants|Arsenic|Particulate Matter,0,
helper T cell extravasation,GO:0035684,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
helper T cell extravasation,GO:0035684,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CCL2
heme catabolic process,GO:0042167,"Tuberculosis, Pulmonary",MESH:D014397,1,Carbon Monoxide,0,
heme metabolic process,GO:0042168,Tuberculosis,MESH:D014376,1,Iron,0,
hemoglobin biosynthetic process,GO:0042541,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
hemoglobin biosynthetic process,GO:0042541,"Tuberculosis, Pulmonary",MESH:D014397,3,Air Pollutants|Nitrogen Dioxide|Particulate Matter,0,
hemoglobin metabolic process,GO:0020027,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
hemoglobin metabolic process,GO:0020027,Tuberculosis,MESH:D014376,1,Iron,0,
hemoglobin metabolic process,GO:0020027,"Tuberculosis, Pulmonary",MESH:D014397,2,Carbon Monoxide|Particulate Matter,0,
hemopoiesis,GO:0030097,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,IFNGR1
hemopoiesis,GO:0030097,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
hepatocyte apoptotic process,GO:0097284,Paratuberculosis,MESH:D010283,0,,1,GSN
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0007157,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CD209
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0007157,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CD209
heterotypic cell-cell adhesion,GO:0034113,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
heterotypic cell-cell adhesion,GO:0034113,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
hippocampus development,GO:0021766,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
hippocampus development,GO:0021766,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
histamine secretion mediated by immunoglobulin,GO:0097280,Tuberculosis,MESH:D014376,5,Chenodeoxycholic Acid|Kanamycin|Ofloxacin|Prednisolone|Streptomycin,0,
histamine secretion mediated by immunoglobulin,GO:0097280,"Tuberculosis, Central Nervous System",MESH:D020306,1,Streptomycin,0,
histamine secretion mediated by immunoglobulin,GO:0097280,"Tuberculosis, Lymph Node",MESH:D014388,1,Ofloxacin,0,
histamine secretion mediated by immunoglobulin,GO:0097280,"Tuberculosis, Meningeal",MESH:D014390,1,Streptomycin,0,
histamine secretion mediated by immunoglobulin,GO:0097280,"Tuberculosis, Multidrug-Resistant",MESH:D018088,2,Kanamycin|Ofloxacin,0,
histamine secretion mediated by immunoglobulin,GO:0097280,"Tuberculosis, Osteoarticular",MESH:D014394,2,Ofloxacin|Prednisolone,0,
histamine secretion mediated by immunoglobulin,GO:0097280,"Tuberculosis, Pulmonary",MESH:D014397,2,Ofloxacin|Streptomycin,0,
histamine secretion mediated by immunoglobulin,GO:0097280,"Tuberculosis, Renal",MESH:D014398,1,Streptomycin,0,
histamine secretion mediated by immunoglobulin,GO:0097280,"Tuberculosis, Spinal",MESH:D014399,1,Streptomycin,0,
histone acetylation,GO:0016573,Tuberculosis,MESH:D014376,1,Gentamicins,0,
histone H3 acetylation,GO:0043966,Tuberculosis,MESH:D014376,2,Rifampin|Tretinoin,0,
histone H3 acetylation,GO:0043966,"Tuberculosis, Central Nervous System",MESH:D020306,1,Rifampin,0,
histone H3 acetylation,GO:0043966,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Rifampin,0,
histone H3 acetylation,GO:0043966,"Tuberculosis, Lymph Node",MESH:D014388,1,Rifampin,0,
histone H3 acetylation,GO:0043966,"Tuberculosis, Meningeal",MESH:D014390,1,Rifampin,0,
histone H3 acetylation,GO:0043966,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Rifampin,0,
histone H3 acetylation,GO:0043966,"Tuberculosis, Pleural",MESH:D014396,1,Rifampin,0,
histone H3 acetylation,GO:0043966,"Tuberculosis, Pulmonary",MESH:D014397,1,Rifampin,0,
histone H3 acetylation,GO:0043966,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
histone H3 acetylation,GO:0043966,"Tuberculosis, Spinal",MESH:D014399,1,Rifampin,0,
histone H3-K18 acetylation,GO:0043971,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
histone H3-K36 dimethylation,GO:0097676,Tuberculosis,MESH:D014376,1,Tretinoin,0,
histone H3-K36 dimethylation,GO:0097676,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
histone H3-K36 trimethylation,GO:0097198,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
histone H3-K4 dimethylation,GO:0044648,Tuberculosis,MESH:D014376,1,Iron,0,
histone H3-K4 dimethylation,GO:0044648,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
histone H3-K4 trimethylation,GO:0080182,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
histone H3-K9 acetylation,GO:0043970,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
histone H3-K9 dimethylation,GO:0036123,Tuberculosis,MESH:D014376,1,Iron,0,
histone H3-K9 dimethylation,GO:0036123,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
histone H4 acetylation,GO:0043967,Tuberculosis,MESH:D014376,1,Rifampin,0,
histone H4 acetylation,GO:0043967,"Tuberculosis, Central Nervous System",MESH:D020306,1,Rifampin,0,
histone H4 acetylation,GO:0043967,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Rifampin,0,
histone H4 acetylation,GO:0043967,"Tuberculosis, Lymph Node",MESH:D014388,1,Rifampin,0,
histone H4 acetylation,GO:0043967,"Tuberculosis, Meningeal",MESH:D014390,1,Rifampin,0,
histone H4 acetylation,GO:0043967,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Rifampin,0,
histone H4 acetylation,GO:0043967,"Tuberculosis, Pleural",MESH:D014396,1,Rifampin,0,
histone H4 acetylation,GO:0043967,"Tuberculosis, Pulmonary",MESH:D014397,1,Rifampin,0,
histone H4 acetylation,GO:0043967,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
histone H4 acetylation,GO:0043967,"Tuberculosis, Spinal",MESH:D014399,1,Rifampin,0,
histone H4-K12 acetylation,GO:0043983,Tuberculosis,MESH:D014376,1,Rifampin,0,
histone H4-K12 acetylation,GO:0043983,"Tuberculosis, Central Nervous System",MESH:D020306,1,Rifampin,0,
histone H4-K12 acetylation,GO:0043983,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Rifampin,0,
histone H4-K12 acetylation,GO:0043983,"Tuberculosis, Lymph Node",MESH:D014388,1,Rifampin,0,
histone H4-K12 acetylation,GO:0043983,"Tuberculosis, Meningeal",MESH:D014390,1,Rifampin,0,
histone H4-K12 acetylation,GO:0043983,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Rifampin,0,
histone H4-K12 acetylation,GO:0043983,"Tuberculosis, Pleural",MESH:D014396,1,Rifampin,0,
histone H4-K12 acetylation,GO:0043983,"Tuberculosis, Pulmonary",MESH:D014397,1,Rifampin,0,
histone H4-K12 acetylation,GO:0043983,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
histone H4-K12 acetylation,GO:0043983,"Tuberculosis, Spinal",MESH:D014399,1,Rifampin,0,
histone H4-K16 acetylation,GO:0043984,Tuberculosis,MESH:D014376,1,Tretinoin,0,
histone H4-K16 acetylation,GO:0043984,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
histone H4-R3 methylation,GO:0043985,Tuberculosis,MESH:D014376,1,Rifampin,0,
histone H4-R3 methylation,GO:0043985,"Tuberculosis, Central Nervous System",MESH:D020306,1,Rifampin,0,
histone H4-R3 methylation,GO:0043985,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Rifampin,0,
histone H4-R3 methylation,GO:0043985,"Tuberculosis, Lymph Node",MESH:D014388,1,Rifampin,0,
histone H4-R3 methylation,GO:0043985,"Tuberculosis, Meningeal",MESH:D014390,1,Rifampin,0,
histone H4-R3 methylation,GO:0043985,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Rifampin,0,
histone H4-R3 methylation,GO:0043985,"Tuberculosis, Pleural",MESH:D014396,1,Rifampin,0,
histone H4-R3 methylation,GO:0043985,"Tuberculosis, Pulmonary",MESH:D014397,1,Rifampin,0,
histone H4-R3 methylation,GO:0043985,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
histone H4-R3 methylation,GO:0043985,"Tuberculosis, Spinal",MESH:D014399,1,Rifampin,0,
histone modification,GO:0016570,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
histone modification,GO:0016570,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
homeostasis of number of cells within a tissue,GO:0048873,Tuberculosis,MESH:D014376,0,,1,CORO1A
homotypic cell-cell adhesion,GO:0034109,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
homotypic cell-cell adhesion,GO:0034109,"Tuberculosis, Pulmonary",MESH:D014397,2,Arsenic|Particulate Matter,0,
host-mediated regulation of intestinal microbiota composition,GO:0048874,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
host-mediated regulation of intestinal microbiota composition,GO:0048874,Tuberculosis,MESH:D014376,1,Gentamicins,0,
host-mediated regulation of intestinal microbiota composition,GO:0048874,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
humoral immune response,GO:0006959,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,2,CCL2|IFNG
humoral immune response,GO:0006959,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CCL2
humoral immune response mediated by circulating immunoglobulin,GO:0002455,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
hydrogen peroxide biosynthetic process,GO:0050665,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
hydrogen peroxide biosynthetic process,GO:0050665,Tuberculosis,MESH:D014376,1,Prednisolone,0,
hydrogen peroxide biosynthetic process,GO:0050665,"Tuberculosis, Osteoarticular",MESH:D014394,1,Prednisolone,0,
hydrogen peroxide biosynthetic process,GO:0050665,"Tuberculosis, Pulmonary",MESH:D014397,3,Arsenic|Particulate Matter|Sulfur Dioxide,0,
hydrogen peroxide metabolic process,GO:0042743,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Air Pollutants,0,
hydrogen peroxide metabolic process,GO:0042743,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Arsenic,0,
hydrogen sulfide biosynthetic process,GO:0070814,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
hypermethylation of CpG island,GO:0044027,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
hypomethylation of CpG island,GO:0044029,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Air Pollutants,0,
hypomethylation of CpG island,GO:0044029,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Nitrogen Dioxide,0,
I-kappaB kinase/NF-kappaB signaling,GO:0007249,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,TIRAP
I-kappaB kinase/NF-kappaB signaling,GO:0007249,Tuberculosis,MESH:D014376,0,,1,TIRAP
I-kappaB phosphorylation,GO:0007252,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,TLR2
immune response,GO:0006955,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,3,CCL2|IFNG|TLR2
immune response,GO:0006955,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,0,,2,HLA-DQA1|TNFSF8
immune response,GO:0006955,Paratuberculosis,MESH:D010283,0,,2,C1R|C3
immune response,GO:0006955,"Tuberculosis, Bovine",MESH:D014380,0,,1,IL4
immune response,GO:0006955,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CCL2
immune system process,GO:0002376,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,TLR2
immune system process,GO:0002376,Tuberculosis,MESH:D014376,1,Tretinoin,1,HP
immunoglobulin production involved in immunoglobulin-mediated immune response,GO:0002381,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
immunoglobulin production involved in immunoglobulin-mediated immune response,GO:0002381,"Tuberculosis, Pulmonary",MESH:D014397,2,Arsenic|Particulate Matter,0,
import across plasma membrane,GO:0098739,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
import across plasma membrane,GO:0098739,Tuberculosis,MESH:D014376,2,Chenodeoxycholic Acid|Isoniazid,0,
import across plasma membrane,GO:0098739,"Tuberculosis, Central Nervous System",MESH:D020306,1,Isoniazid,0,
import across plasma membrane,GO:0098739,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Isoniazid,0,
import across plasma membrane,GO:0098739,"Tuberculosis, Lymph Node",MESH:D014388,1,Isoniazid,0,
import across plasma membrane,GO:0098739,"Tuberculosis, Meningeal",MESH:D014390,1,Isoniazid,0,
import across plasma membrane,GO:0098739,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Isoniazid,0,
import across plasma membrane,GO:0098739,"Tuberculosis, Pleural",MESH:D014396,1,Isoniazid,0,
import across plasma membrane,GO:0098739,"Tuberculosis, Pulmonary",MESH:D014397,1,Isoniazid,0,
import across plasma membrane,GO:0098739,"Tuberculosis, Spinal",MESH:D014399,1,Isoniazid,0,
import into cell,GO:0098657,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
import into cell,GO:0098657,Tuberculosis,MESH:D014376,2,Iron|Rifampin,0,
import into cell,GO:0098657,"Tuberculosis, Central Nervous System",MESH:D020306,1,Rifampin,0,
import into cell,GO:0098657,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Rifampin,0,
import into cell,GO:0098657,"Tuberculosis, Lymph Node",MESH:D014388,1,Rifampin,0,
import into cell,GO:0098657,"Tuberculosis, Meningeal",MESH:D014390,1,Rifampin,0,
import into cell,GO:0098657,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Rifampin,0,
import into cell,GO:0098657,"Tuberculosis, Pleural",MESH:D014396,1,Rifampin,0,
import into cell,GO:0098657,"Tuberculosis, Pulmonary",MESH:D014397,2,Particulate Matter|Rifampin,0,
import into cell,GO:0098657,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
import into cell,GO:0098657,"Tuberculosis, Spinal",MESH:D014399,1,Rifampin,0,
inflammatory cell apoptotic process,GO:0006925,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,IFNG
inflammatory cell apoptotic process,GO:0006925,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
inflammatory cell apoptotic process,GO:0006925,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
inflammatory response,GO:0006954,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
inflammatory response,GO:0006954,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,5,CCL2|IRGM|SLC11A1|TIRAP|TLR2
inflammatory response,GO:0006954,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
inflammatory response,GO:0006954,Paratuberculosis,MESH:D010283,0,,2,AOC3|C3
inflammatory response,GO:0006954,Tuberculosis,MESH:D014376,4,Gentamicins|Iron|Isoniazid|Verapamil,2,SLC11A1|TIRAP
inflammatory response,GO:0006954,"Tuberculosis, Central Nervous System",MESH:D020306,1,Isoniazid,0,
inflammatory response,GO:0006954,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Isoniazid,0,
inflammatory response,GO:0006954,"Tuberculosis, Lymph Node",MESH:D014388,1,Isoniazid,0,
inflammatory response,GO:0006954,"Tuberculosis, Meningeal",MESH:D014390,1,Isoniazid,0,
inflammatory response,GO:0006954,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Isoniazid,0,
inflammatory response,GO:0006954,"Tuberculosis, Pleural",MESH:D014396,1,Isoniazid,0,
inflammatory response,GO:0006954,"Tuberculosis, Pulmonary",MESH:D014397,6,Air Pollutants|Arsenic|Carbon Monoxide|Isoniazid|Particulate Matter|Sulfur Dioxide,1,CCL2
inflammatory response,GO:0006954,"Tuberculosis, Spinal",MESH:D014399,1,Isoniazid,0,
inflammatory response to antigenic stimulus,GO:0002437,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
inflammatory response to antigenic stimulus,GO:0002437,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
inflammatory response to wounding,GO:0090594,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,TLR2
initiation of primordial ovarian follicle growth,GO:0001544,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
initiation of primordial ovarian follicle growth,GO:0001544,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
innate immune response,GO:0045087,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,5,CD209|IRGM|SP110|TIRAP|TLR2
innate immune response,GO:0045087,Paratuberculosis,MESH:D010283,0,,2,C1R|C3
innate immune response,GO:0045087,Tuberculosis,MESH:D014376,0,,2,CORO1A|TIRAP
innate immune response,GO:0045087,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,2,CD209|MMP3
innate immune response in mucosa,GO:0002227,"Tuberculosis, Bovine",MESH:D014380,0,,1,IL4
innervation,GO:0060384,Paratuberculosis,MESH:D010283,0,,1,C3
insulin metabolic process,GO:1901142,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
insulin metabolic process,GO:1901142,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
insulin receptor signaling pathway via phosphatidylinositol 3-kinase,GO:0038028,Tuberculosis,MESH:D014376,1,Verapamil,0,
insulin secretion involved in cellular response to glucose stimulus,GO:0035773,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
interleukin-10 production,GO:0032613,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
interleukin-10 production,GO:0032613,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
interleukin-12 production,GO:0032615,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,IFNG
interleukin-17 production,GO:0032620,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,TLR2
interleukin-1 beta production,GO:0032611,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
interleukin-2 production,GO:0032623,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,SLC11A1
interleukin-2 production,GO:0032623,Tuberculosis,MESH:D014376,0,,1,SLC11A1
interleukin-3 production,GO:0032632,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,SLC11A1
interleukin-3 production,GO:0032632,Tuberculosis,MESH:D014376,0,,1,SLC11A1
interleukin-4-mediated signaling pathway,GO:0035771,"Tuberculosis, Bovine",MESH:D014380,0,,1,IL4
interleukin-5 production,GO:0032634,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
interleukin-5 production,GO:0032634,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
interleukin-6 production,GO:0032635,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,TLR2
interleukin-6 production,GO:0032635,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Air Pollutants,0,
interleukin-6 production,GO:0032635,"Tuberculosis, Pulmonary",MESH:D014397,3,Air Pollutants|Nitrogen Dioxide|Sulfur Dioxide,0,
interleukin-7 production,GO:0032636,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
intestinal D-glucose absorption,GO:0001951,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
intestinal epithelial cell maturation,GO:0060574,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
intestine smooth muscle contraction,GO:0014827,Tuberculosis,MESH:D014376,1,Verapamil,0,
intracellular pH reduction,GO:0051452,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
intracellular signal transduction,GO:0035556,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,3,CD209|CISH|TLR2
intracellular signal transduction,GO:0035556,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CD209
intracellular transport of virus,GO:0075733,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CD209
intracellular transport of virus,GO:0075733,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CD209
iron import into cell,GO:0033212,Tuberculosis,MESH:D014376,1,Iron,0,
iron ion homeostasis,GO:0055072,Extensively Drug-Resistant Tuberculosis,MESH:D054908,1,Ethambutol,0,
iron ion homeostasis,GO:0055072,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
iron ion homeostasis,GO:0055072,Tuberculosis,MESH:D014376,5,Ethambutol|Iron|Isoniazid|Pyrazinamide|Rifampin,0,
iron ion homeostasis,GO:0055072,"Tuberculosis, Central Nervous System",MESH:D020306,4,Ethambutol|Isoniazid|Pyrazinamide|Rifampin,0,
iron ion homeostasis,GO:0055072,"Tuberculosis, Gastrointestinal",MESH:D014385,2,Isoniazid|Rifampin,0,
iron ion homeostasis,GO:0055072,"Tuberculosis, Lymph Node",MESH:D014388,4,Ethambutol|Isoniazid|Pyrazinamide|Rifampin,0,
iron ion homeostasis,GO:0055072,"Tuberculosis, Meningeal",MESH:D014390,3,Isoniazid|Pyrazinamide|Rifampin,0,
iron ion homeostasis,GO:0055072,"Tuberculosis, Miliary",MESH:D014391,1,Ethambutol,0,
iron ion homeostasis,GO:0055072,"Tuberculosis, Multidrug-Resistant",MESH:D018088,4,Ethambutol|Isoniazid|Pyrazinamide|Rifampin,0,
iron ion homeostasis,GO:0055072,"Tuberculosis, Osteoarticular",MESH:D014394,1,Ethambutol,0,
iron ion homeostasis,GO:0055072,"Tuberculosis, Pleural",MESH:D014396,3,Ethambutol|Isoniazid|Rifampin,0,
iron ion homeostasis,GO:0055072,"Tuberculosis, Pulmonary",MESH:D014397,4,Ethambutol|Isoniazid|Pyrazinamide|Rifampin,0,
iron ion homeostasis,GO:0055072,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
iron ion homeostasis,GO:0055072,"Tuberculosis, Spinal",MESH:D014399,4,Ethambutol|Isoniazid|Pyrazinamide|Rifampin,0,
iron ion import across plasma membrane,GO:0098711,Tuberculosis,MESH:D014376,1,Iron,0,
iron ion transmembrane transport,GO:0034755,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,SLC11A1
iron ion transmembrane transport,GO:0034755,Tuberculosis,MESH:D014376,0,,1,SLC11A1
iron ion transport,GO:0006826,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,SLC11A1
iron ion transport,GO:0006826,Paratuberculosis,MESH:D010283,0,,1,TF
iron ion transport,GO:0006826,Tuberculosis,MESH:D014376,2,Iron|Verapamil,1,SLC11A1
isocitrate metabolic process,GO:0006102,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
isotype switching to IgE isotypes,GO:0048289,"Tuberculosis, Bovine",MESH:D014380,0,,1,IL4
isotype switching to IgG isotypes,GO:0048291,"Tuberculosis, Bovine",MESH:D014380,0,,1,IL4
keratinocyte differentiation,GO:0030216,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Air Pollutants,0,
keratinocyte differentiation,GO:0030216,"Tuberculosis, Pulmonary",MESH:D014397,1,Air Pollutants,0,
lactate biosynthetic process,GO:0019249,Extensively Drug-Resistant Tuberculosis,MESH:D054908,1,Tolcapone,0,
lactate biosynthetic process,GO:0019249,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
lactate biosynthetic process,GO:0019249,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
lactate biosynthetic process,GO:0019249,Tuberculosis,MESH:D014376,3,Isoniazid|Pyrazinamide|Rifampin,0,
lactate biosynthetic process,GO:0019249,"Tuberculosis, Central Nervous System",MESH:D020306,3,Isoniazid|Pyrazinamide|Rifampin,0,
lactate biosynthetic process,GO:0019249,"Tuberculosis, Gastrointestinal",MESH:D014385,2,Isoniazid|Rifampin,0,
lactate biosynthetic process,GO:0019249,"Tuberculosis, Lymph Node",MESH:D014388,3,Isoniazid|Pyrazinamide|Rifampin,0,
lactate biosynthetic process,GO:0019249,"Tuberculosis, Meningeal",MESH:D014390,3,Isoniazid|Pyrazinamide|Rifampin,0,
lactate biosynthetic process,GO:0019249,"Tuberculosis, Multidrug-Resistant",MESH:D018088,4,Isoniazid|Pyrazinamide|Rifampin|Tolcapone,0,
lactate biosynthetic process,GO:0019249,"Tuberculosis, Pleural",MESH:D014396,2,Isoniazid|Rifampin,0,
lactate biosynthetic process,GO:0019249,"Tuberculosis, Pulmonary",MESH:D014397,5,Air Pollutants|Isoniazid|Particulate Matter|Pyrazinamide|Rifampin,0,
lactate biosynthetic process,GO:0019249,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
lactate biosynthetic process,GO:0019249,"Tuberculosis, Spinal",MESH:D014399,3,Isoniazid|Pyrazinamide|Rifampin,0,
lactate metabolic process,GO:0006089,Extensively Drug-Resistant Tuberculosis,MESH:D054908,1,Ethambutol,0,
lactate metabolic process,GO:0006089,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
lactate metabolic process,GO:0006089,Tuberculosis,MESH:D014376,2,"Ethambutol|isoniazid, pyrazinamide, rifampin drug combination",0,
lactate metabolic process,GO:0006089,"Tuberculosis, Central Nervous System",MESH:D020306,1,Ethambutol,0,
lactate metabolic process,GO:0006089,"Tuberculosis, Lymph Node",MESH:D014388,2,"Ethambutol|isoniazid, pyrazinamide, rifampin drug combination",0,
lactate metabolic process,GO:0006089,"Tuberculosis, Miliary",MESH:D014391,2,"Ethambutol|isoniazid, pyrazinamide, rifampin drug combination",0,
lactate metabolic process,GO:0006089,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Ethambutol,0,
lactate metabolic process,GO:0006089,"Tuberculosis, Osteoarticular",MESH:D014394,2,"Ethambutol|isoniazid, pyrazinamide, rifampin drug combination",0,
lactate metabolic process,GO:0006089,"Tuberculosis, Pleural",MESH:D014396,1,Ethambutol,0,
lactate metabolic process,GO:0006089,"Tuberculosis, Pulmonary",MESH:D014397,4,"Arsenic|Ethambutol|isoniazid, pyrazinamide, rifampin drug combination|Particulate Matter",0,
lactate metabolic process,GO:0006089,"Tuberculosis, Spinal",MESH:D014399,1,Ethambutol,0,
lactone metabolic process,GO:1901334,Tuberculosis,MESH:D014376,1,Tretinoin,0,
lactose metabolic process,GO:0005988,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
L-arginine transmembrane transport,GO:1903826,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,SLC11A1
L-arginine transmembrane transport,GO:1903826,Tuberculosis,MESH:D014376,0,,1,SLC11A1
larval development,GO:0002164,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
larval development,GO:0002164,"Tuberculosis, Pulmonary",MESH:D014397,2,Arsenic|Particulate Matter,0,
larval locomotory behavior,GO:0008345,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
larval locomotory behavior,GO:0008345,"Tuberculosis, Pulmonary",MESH:D014397,3,Air Pollutants|Arsenic|Particulate Matter,0,
L-ascorbic acid metabolic process,GO:0019852,Tuberculosis,MESH:D014376,1,Iron,0,
L-ascorbic acid metabolic process,GO:0019852,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
L-cystine transport,GO:0015811,Tuberculosis,MESH:D014376,1,Tretinoin,0,
learning,GO:0007612,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,TLR2
learning,GO:0007612,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
learning,GO:0007612,Tuberculosis,MESH:D014376,1,Tretinoin,0,
learning,GO:0007612,"Tuberculosis, Pulmonary",MESH:D014397,4,Air Pollutants|Arsenic|Carbon Monoxide|Particulate Matter,0,
learning or memory,GO:0007611,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
learning or memory,GO:0007611,"Tuberculosis, Pulmonary",MESH:D014397,3,Air Pollutants|Arsenic|Particulate Matter,0,
leukocyte adhesion to vascular endothelial cell,GO:0061756,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
leukocyte adhesion to vascular endothelial cell,GO:0061756,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
leukocyte adhesive activation,GO:0050902,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
leukocyte adhesive activation,GO:0050902,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
leukocyte cell-cell adhesion,GO:0007159,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CD209
leukocyte cell-cell adhesion,GO:0007159,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CD209
leukocyte chemotaxis,GO:0030595,Tuberculosis,MESH:D014376,4,Chenodeoxycholic Acid|Gentamicins|Prednisolone|Rifampin,1,CORO1A
leukocyte chemotaxis,GO:0030595,"Tuberculosis, Central Nervous System",MESH:D020306,1,Rifampin,0,
leukocyte chemotaxis,GO:0030595,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Rifampin,0,
leukocyte chemotaxis,GO:0030595,"Tuberculosis, Lymph Node",MESH:D014388,1,Rifampin,0,
leukocyte chemotaxis,GO:0030595,"Tuberculosis, Meningeal",MESH:D014390,1,Rifampin,0,
leukocyte chemotaxis,GO:0030595,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Rifampin,0,
leukocyte chemotaxis,GO:0030595,"Tuberculosis, Osteoarticular",MESH:D014394,1,Prednisolone,0,
leukocyte chemotaxis,GO:0030595,"Tuberculosis, Pleural",MESH:D014396,1,Rifampin,0,
leukocyte chemotaxis,GO:0030595,"Tuberculosis, Pulmonary",MESH:D014397,2,Clarithromycin|Rifampin,0,
leukocyte chemotaxis,GO:0030595,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
leukocyte chemotaxis,GO:0030595,"Tuberculosis, Spinal",MESH:D014399,1,Rifampin,0,
leukocyte degranulation,GO:0043299,"Tuberculosis, Pulmonary",MESH:D014397,1,Aminosalicylic Acids,0,
leukocyte homeostasis,GO:0001776,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
leukocyte homeostasis,GO:0001776,"Tuberculosis, Pulmonary",MESH:D014397,4,Carbon Monoxide|Nitrogen Dioxide|Particulate Matter|Sulfur Dioxide,0,
leukocyte migration,GO:0050900,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,TLR2
leukocyte migration,GO:0050900,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
leukocyte migration,GO:0050900,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
leukocyte migration involved in immune response,GO:0002522,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
leukocyte migration involved in immune response,GO:0002522,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
leukocyte migration involved in inflammatory response,GO:0002523,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
leukocyte migration involved in inflammatory response,GO:0002523,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
leukocyte migration involved in inflammatory response,GO:0002523,Paratuberculosis,MESH:D010283,0,,1,AOC3
leukocyte migration involved in inflammatory response,GO:0002523,Tuberculosis,MESH:D014376,5,Gentamicins|Iron|Prednisolone|Rifampin|Tretinoin,0,
leukocyte migration involved in inflammatory response,GO:0002523,"Tuberculosis, Central Nervous System",MESH:D020306,1,Rifampin,0,
leukocyte migration involved in inflammatory response,GO:0002523,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Rifampin,0,
leukocyte migration involved in inflammatory response,GO:0002523,"Tuberculosis, Lymph Node",MESH:D014388,1,Rifampin,0,
leukocyte migration involved in inflammatory response,GO:0002523,"Tuberculosis, Meningeal",MESH:D014390,1,Rifampin,0,
leukocyte migration involved in inflammatory response,GO:0002523,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Rifampin,0,
leukocyte migration involved in inflammatory response,GO:0002523,"Tuberculosis, Osteoarticular",MESH:D014394,1,Prednisolone,0,
leukocyte migration involved in inflammatory response,GO:0002523,"Tuberculosis, Pleural",MESH:D014396,1,Rifampin,0,
leukocyte migration involved in inflammatory response,GO:0002523,"Tuberculosis, Pulmonary",MESH:D014397,7,Air Pollutants|Arsenic|Carbon Monoxide|Nitrogen Dioxide|Particulate Matter|Rifampin|Sulfur Dioxide,1,CCL2
leukocyte migration involved in inflammatory response,GO:0002523,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
leukocyte migration involved in inflammatory response,GO:0002523,"Tuberculosis, Spinal",MESH:D014399,1,Rifampin,0,
leukotriene metabolic process,GO:0006691,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,TLR2
Leydig cell differentiation,GO:0033327,Tuberculosis,MESH:D014376,1,Tretinoin,0,
Leydig cell differentiation,GO:0033327,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
L-glutamate transmembrane transport,GO:0015813,Tuberculosis,MESH:D014376,1,Tretinoin,0,
ligand-gated ion channel signaling pathway,GO:1990806,Paratuberculosis,MESH:D010283,0,,1,F2
lipid biosynthetic process,GO:0008610,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
lipid biosynthetic process,GO:0008610,Tuberculosis,MESH:D014376,3,Iron|Isoniazid|Rifampin,0,
lipid biosynthetic process,GO:0008610,"Tuberculosis, Central Nervous System",MESH:D020306,2,Isoniazid|Rifampin,0,
lipid biosynthetic process,GO:0008610,"Tuberculosis, Gastrointestinal",MESH:D014385,2,Isoniazid|Rifampin,0,
lipid biosynthetic process,GO:0008610,"Tuberculosis, Lymph Node",MESH:D014388,2,Isoniazid|Rifampin,0,
lipid biosynthetic process,GO:0008610,"Tuberculosis, Meningeal",MESH:D014390,2,Isoniazid|Rifampin,0,
lipid biosynthetic process,GO:0008610,"Tuberculosis, Multidrug-Resistant",MESH:D018088,2,Isoniazid|Rifampin,0,
lipid biosynthetic process,GO:0008610,"Tuberculosis, Pleural",MESH:D014396,2,Isoniazid|Rifampin,0,
lipid biosynthetic process,GO:0008610,"Tuberculosis, Pulmonary",MESH:D014397,2,Isoniazid|Rifampin,0,
lipid biosynthetic process,GO:0008610,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
lipid biosynthetic process,GO:0008610,"Tuberculosis, Spinal",MESH:D014399,2,Isoniazid|Rifampin,0,
lipid catabolic process,GO:0016042,Extensively Drug-Resistant Tuberculosis,MESH:D054908,1,Ethambutol,0,
lipid catabolic process,GO:0016042,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
lipid catabolic process,GO:0016042,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
lipid catabolic process,GO:0016042,Tuberculosis,MESH:D014376,10,Ciprofloxacin|Ethambutol|Gentamicins|Iron|Isoniazid|Ofloxacin|Prednisolone|Pyrazinamide|Rifampin|Verapamil,0,
lipid catabolic process,GO:0016042,"Tuberculosis, Central Nervous System",MESH:D020306,4,Ethambutol|Isoniazid|Pyrazinamide|Rifampin,0,
lipid catabolic process,GO:0016042,"Tuberculosis, Gastrointestinal",MESH:D014385,2,Isoniazid|Rifampin,0,
lipid catabolic process,GO:0016042,"Tuberculosis, Lymph Node",MESH:D014388,5,Ethambutol|Isoniazid|Ofloxacin|Pyrazinamide|Rifampin,0,
lipid catabolic process,GO:0016042,"Tuberculosis, Meningeal",MESH:D014390,3,Isoniazid|Pyrazinamide|Rifampin,0,
lipid catabolic process,GO:0016042,"Tuberculosis, Miliary",MESH:D014391,1,Ethambutol,0,
lipid catabolic process,GO:0016042,"Tuberculosis, Multidrug-Resistant",MESH:D018088,5,Ethambutol|Isoniazid|Ofloxacin|Pyrazinamide|Rifampin,0,
lipid catabolic process,GO:0016042,"Tuberculosis, Osteoarticular",MESH:D014394,3,Ethambutol|Ofloxacin|Prednisolone,0,
lipid catabolic process,GO:0016042,"Tuberculosis, Pleural",MESH:D014396,3,Ethambutol|Isoniazid|Rifampin,0,
lipid catabolic process,GO:0016042,"Tuberculosis, Pulmonary",MESH:D014397,9,Air Pollutants|Arsenic|Ethambutol|Isoniazid|Ofloxacin|Particulate Matter|Pyrazinamide|Rifampin|Sulfur Dioxide,0,
lipid catabolic process,GO:0016042,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
lipid catabolic process,GO:0016042,"Tuberculosis, Spinal",MESH:D014399,5,Ciprofloxacin|Ethambutol|Isoniazid|Pyrazinamide|Rifampin,0,
lipid droplet formation,GO:0140042,Extensively Drug-Resistant Tuberculosis,MESH:D054908,1,Ethambutol,0,
lipid droplet formation,GO:0140042,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
lipid droplet formation,GO:0140042,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
lipid droplet formation,GO:0140042,Tuberculosis,MESH:D014376,9,Chenodeoxycholic Acid|Ciprofloxacin|Ethambutol|Iron|Isoniazid|Ofloxacin|Prednisolone|Pyrazinamide|Rifampin,0,
lipid droplet formation,GO:0140042,"Tuberculosis, Central Nervous System",MESH:D020306,4,Ethambutol|Isoniazid|Pyrazinamide|Rifampin,0,
lipid droplet formation,GO:0140042,"Tuberculosis, Gastrointestinal",MESH:D014385,2,Isoniazid|Rifampin,0,
lipid droplet formation,GO:0140042,"Tuberculosis, Lymph Node",MESH:D014388,5,Ethambutol|Isoniazid|Ofloxacin|Pyrazinamide|Rifampin,0,
lipid droplet formation,GO:0140042,"Tuberculosis, Meningeal",MESH:D014390,3,Isoniazid|Pyrazinamide|Rifampin,0,
lipid droplet formation,GO:0140042,"Tuberculosis, Miliary",MESH:D014391,1,Ethambutol,0,
lipid droplet formation,GO:0140042,"Tuberculosis, Multidrug-Resistant",MESH:D018088,5,Ethambutol|Isoniazid|Ofloxacin|Pyrazinamide|Rifampin,0,
lipid droplet formation,GO:0140042,"Tuberculosis, Osteoarticular",MESH:D014394,3,Ethambutol|Ofloxacin|Prednisolone,0,
lipid droplet formation,GO:0140042,"Tuberculosis, Pleural",MESH:D014396,3,Ethambutol|Isoniazid|Rifampin,0,
lipid droplet formation,GO:0140042,"Tuberculosis, Pulmonary",MESH:D014397,9,Air Pollutants|Arsenic|Clarithromycin|Ethambutol|Isoniazid|Ofloxacin|Particulate Matter|Pyrazinamide|Rifampin,0,
lipid droplet formation,GO:0140042,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
lipid droplet formation,GO:0140042,"Tuberculosis, Spinal",MESH:D014399,5,Ciprofloxacin|Ethambutol|Isoniazid|Pyrazinamide|Rifampin,0,
lipid homeostasis,GO:0055088,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
lipid metabolic process,GO:0006629,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
lipid metabolic process,GO:0006629,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
lipid metabolic process,GO:0006629,Tuberculosis,MESH:D014376,2,Chenodeoxycholic Acid|Isoniazid,1,HP
lipid metabolic process,GO:0006629,"Tuberculosis, Central Nervous System",MESH:D020306,1,Isoniazid,0,
lipid metabolic process,GO:0006629,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Isoniazid,0,
lipid metabolic process,GO:0006629,"Tuberculosis, Lymph Node",MESH:D014388,1,Isoniazid,0,
lipid metabolic process,GO:0006629,"Tuberculosis, Meningeal",MESH:D014390,1,Isoniazid,0,
lipid metabolic process,GO:0006629,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Isoniazid,0,
lipid metabolic process,GO:0006629,"Tuberculosis, Pleural",MESH:D014396,1,Isoniazid,0,
lipid metabolic process,GO:0006629,"Tuberculosis, Pulmonary",MESH:D014397,3,Air Pollutants|Isoniazid|Particulate Matter,0,
lipid metabolic process,GO:0006629,"Tuberculosis, Spinal",MESH:D014399,1,Isoniazid,0,
lipid oxidation,GO:0034440,Extensively Drug-Resistant Tuberculosis,MESH:D054908,1,Ethambutol,0,
lipid oxidation,GO:0034440,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
lipid oxidation,GO:0034440,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
lipid oxidation,GO:0034440,Tuberculosis,MESH:D014376,12,"Ciprofloxacin|Ethambutol|Gentamicins|Iron|Isoniazid|isoniazid, pyrazinamide, rifampin drug combination|Prednisolone|Pyrazinamide|Pyrroles|Rifampin|Tretinoin|Verapamil",0,
lipid oxidation,GO:0034440,"Tuberculosis, Central Nervous System",MESH:D020306,4,Ethambutol|Isoniazid|Pyrazinamide|Rifampin,0,
lipid oxidation,GO:0034440,"Tuberculosis, Gastrointestinal",MESH:D014385,2,Isoniazid|Rifampin,0,
lipid oxidation,GO:0034440,"Tuberculosis, Lymph Node",MESH:D014388,5,"Ethambutol|Isoniazid|isoniazid, pyrazinamide, rifampin drug combination|Pyrazinamide|Rifampin",0,
lipid oxidation,GO:0034440,"Tuberculosis, Meningeal",MESH:D014390,3,Isoniazid|Pyrazinamide|Rifampin,0,
lipid oxidation,GO:0034440,"Tuberculosis, Miliary",MESH:D014391,2,"Ethambutol|isoniazid, pyrazinamide, rifampin drug combination",0,
lipid oxidation,GO:0034440,"Tuberculosis, Multidrug-Resistant",MESH:D018088,4,Ethambutol|Isoniazid|Pyrazinamide|Rifampin,0,
lipid oxidation,GO:0034440,"Tuberculosis, Osteoarticular",MESH:D014394,3,"Ethambutol|isoniazid, pyrazinamide, rifampin drug combination|Prednisolone",0,
lipid oxidation,GO:0034440,"Tuberculosis, Pleural",MESH:D014396,3,Ethambutol|Isoniazid|Rifampin,0,
lipid oxidation,GO:0034440,"Tuberculosis, Pulmonary",MESH:D014397,8,"Air Pollutants|Arsenic|Ethambutol|Isoniazid|isoniazid, pyrazinamide, rifampin drug combination|Particulate Matter|Pyrazinamide|Rifampin",0,
lipid oxidation,GO:0034440,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
lipid oxidation,GO:0034440,"Tuberculosis, Spinal",MESH:D014399,5,Ciprofloxacin|Ethambutol|Isoniazid|Pyrazinamide|Rifampin,0,
lipid storage,GO:0019915,Tuberculosis,MESH:D014376,1,Tretinoin,0,
lipopolysaccharide-mediated signaling pathway,GO:0031663,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,TLR2
lipoprotein metabolic process,GO:0042157,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
lipoprotein metabolic process,GO:0042157,Tuberculosis,MESH:D014376,1,Pyrazinamide,0,
lipoprotein metabolic process,GO:0042157,"Tuberculosis, Central Nervous System",MESH:D020306,1,Pyrazinamide,0,
lipoprotein metabolic process,GO:0042157,"Tuberculosis, Lymph Node",MESH:D014388,1,Pyrazinamide,0,
lipoprotein metabolic process,GO:0042157,"Tuberculosis, Meningeal",MESH:D014390,1,Pyrazinamide,0,
lipoprotein metabolic process,GO:0042157,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Pyrazinamide,0,
lipoprotein metabolic process,GO:0042157,"Tuberculosis, Pulmonary",MESH:D014397,2,Particulate Matter|Pyrazinamide,0,
lipoprotein metabolic process,GO:0042157,"Tuberculosis, Spinal",MESH:D014399,1,Pyrazinamide,0,
lipoxygenase pathway,GO:0019372,Tuberculosis,MESH:D014376,1,Chenodeoxycholic Acid,0,
liver development,GO:0001889,Tuberculosis,MESH:D014376,0,,1,HP
locomotion involved in locomotory behavior,GO:0031987,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
locomotion involved in locomotory behavior,GO:0031987,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
locomotion involved in locomotory behavior,GO:0031987,Tuberculosis,MESH:D014376,1,Isoniazid,0,
locomotion involved in locomotory behavior,GO:0031987,"Tuberculosis, Central Nervous System",MESH:D020306,1,Isoniazid,0,
locomotion involved in locomotory behavior,GO:0031987,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Isoniazid,0,
locomotion involved in locomotory behavior,GO:0031987,"Tuberculosis, Lymph Node",MESH:D014388,1,Isoniazid,0,
locomotion involved in locomotory behavior,GO:0031987,"Tuberculosis, Meningeal",MESH:D014390,1,Isoniazid,0,
locomotion involved in locomotory behavior,GO:0031987,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Isoniazid,0,
locomotion involved in locomotory behavior,GO:0031987,"Tuberculosis, Pleural",MESH:D014396,1,Isoniazid,0,
locomotion involved in locomotory behavior,GO:0031987,"Tuberculosis, Pulmonary",MESH:D014397,4,Air Pollutants|Arsenic|Isoniazid|Particulate Matter,0,
locomotion involved in locomotory behavior,GO:0031987,"Tuberculosis, Spinal",MESH:D014399,1,Isoniazid,0,
locomotory behavior,GO:0007626,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
locomotory behavior,GO:0007626,Tuberculosis,MESH:D014376,1,Prednisolone,0,
locomotory behavior,GO:0007626,"Tuberculosis, Osteoarticular",MESH:D014394,1,Prednisolone,0,
locomotory behavior,GO:0007626,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
locomotory exploration behavior,GO:0035641,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
locomotory exploration behavior,GO:0035641,"Tuberculosis, Pulmonary",MESH:D014397,3,Air Pollutants|Arsenic|Particulate Matter,0,
L-phenylalanine metabolic process,GO:0006558,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
L-phenylalanine metabolic process,GO:0006558,"Tuberculosis, Pulmonary",MESH:D014397,3,Air Pollutants|Nitrogen Dioxide|Particulate Matter,0,
lung alveolus development,GO:0048286,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
lung alveolus development,GO:0048286,Tuberculosis,MESH:D014376,1,Tretinoin,0,
lung alveolus development,GO:0048286,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
lung development,GO:0030324,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
lung development,GO:0030324,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
lung epithelium development,GO:0060428,Tuberculosis,MESH:D014376,1,Tretinoin,0,
lung goblet cell differentiation,GO:0060480,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
lung goblet cell differentiation,GO:0060480,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
lung growth,GO:0060437,Tuberculosis,MESH:D014376,1,Tretinoin,0,
lymphocyte activation involved in immune response,GO:0002285,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
lymphocyte activation involved in immune response,GO:0002285,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
lymphocyte chemotaxis,GO:0048247,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
lymphocyte chemotaxis,GO:0048247,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
lymphocyte chemotaxis,GO:0048247,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,1,CCL2
lymphocyte homeostasis,GO:0002260,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
lymphocyte homeostasis,GO:0002260,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
lymphocyte migration,GO:0072676,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
lymphocyte migration,GO:0072676,Tuberculosis,MESH:D014376,1,Iron,0,
lymphocyte migration,GO:0072676,"Tuberculosis, Pulmonary",MESH:D014397,3,Air Pollutants|Particulate Matter|Sulfur Dioxide,0,
lymphocyte proliferation,GO:0046651,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
lymphocyte proliferation,GO:0046651,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
lysosomal lumen acidification,GO:0007042,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
lysosomal lumen acidification,GO:0007042,"Tuberculosis, Pulmonary",MESH:D014397,2,Arsenic|Particulate Matter,0,
lysosomal lumen pH elevation,GO:0035752,Tuberculosis,MESH:D014376,1,Rifampin,0,
lysosomal lumen pH elevation,GO:0035752,"Tuberculosis, Central Nervous System",MESH:D020306,1,Rifampin,0,
lysosomal lumen pH elevation,GO:0035752,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Rifampin,0,
lysosomal lumen pH elevation,GO:0035752,"Tuberculosis, Lymph Node",MESH:D014388,1,Rifampin,0,
lysosomal lumen pH elevation,GO:0035752,"Tuberculosis, Meningeal",MESH:D014390,1,Rifampin,0,
lysosomal lumen pH elevation,GO:0035752,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Rifampin,0,
lysosomal lumen pH elevation,GO:0035752,"Tuberculosis, Pleural",MESH:D014396,1,Rifampin,0,
lysosomal lumen pH elevation,GO:0035752,"Tuberculosis, Pulmonary",MESH:D014397,1,Rifampin,0,
lysosomal lumen pH elevation,GO:0035752,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
lysosomal lumen pH elevation,GO:0035752,"Tuberculosis, Spinal",MESH:D014399,1,Rifampin,0,
lysosome organization,GO:0007040,Tuberculosis,MESH:D014376,2,Ciprofloxacin|Ofloxacin,0,
lysosome organization,GO:0007040,"Tuberculosis, Lymph Node",MESH:D014388,1,Ofloxacin,0,
lysosome organization,GO:0007040,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Ofloxacin,0,
lysosome organization,GO:0007040,"Tuberculosis, Osteoarticular",MESH:D014394,1,Ofloxacin,0,
lysosome organization,GO:0007040,"Tuberculosis, Pulmonary",MESH:D014397,1,Ofloxacin,0,
lysosome organization,GO:0007040,"Tuberculosis, Spinal",MESH:D014399,1,Ciprofloxacin,0,
macrophage activation,GO:0042116,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,SLC11A1
macrophage activation,GO:0042116,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
macrophage activation,GO:0042116,Tuberculosis,MESH:D014376,0,,1,SLC11A1
macrophage activation,GO:0042116,"Tuberculosis, Bovine",MESH:D014380,0,,1,IL4
macrophage activation,GO:0042116,"Tuberculosis, Pulmonary",MESH:D014397,2,Arsenic|Particulate Matter,0,
macrophage activation involved in immune response,GO:0002281,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,IFNG
macrophage activation involved in immune response,GO:0002281,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
macrophage activation involved in immune response,GO:0002281,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
macrophage chemotaxis,GO:0048246,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
macrophage chemotaxis,GO:0048246,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CCL2
macrophage cytokine production,GO:0010934,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,3,IFNG|TIRAP|TLR2
macrophage cytokine production,GO:0010934,Tuberculosis,MESH:D014376,0,,1,TIRAP
macrophage differentiation,GO:0030225,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,IFNG
macrophage differentiation,GO:0030225,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
macrophage differentiation,GO:0030225,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
macrophage homeostasis,GO:0061519,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
macrophage homeostasis,GO:0061519,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
macrophage migration,GO:1905517,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
macrophage migration,GO:1905517,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
macrophage migration,GO:1905517,Tuberculosis,MESH:D014376,1,Isoniazid,0,
macrophage migration,GO:1905517,"Tuberculosis, Central Nervous System",MESH:D020306,1,Isoniazid,0,
macrophage migration,GO:1905517,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Isoniazid,0,
macrophage migration,GO:1905517,"Tuberculosis, Lymph Node",MESH:D014388,1,Isoniazid,0,
macrophage migration,GO:1905517,"Tuberculosis, Meningeal",MESH:D014390,1,Isoniazid,0,
macrophage migration,GO:1905517,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Isoniazid,0,
macrophage migration,GO:1905517,"Tuberculosis, Pleural",MESH:D014396,1,Isoniazid,0,
macrophage migration,GO:1905517,"Tuberculosis, Pulmonary",MESH:D014397,5,Air Pollutants|Arsenic|Isoniazid|Particulate Matter|Sulfur Dioxide,0,
macrophage migration,GO:1905517,"Tuberculosis, Spinal",MESH:D014399,1,Isoniazid,0,
maintenance of blood-brain barrier,GO:0035633,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
maintenance of blood-brain barrier,GO:0035633,Tuberculosis,MESH:D014376,1,Verapamil,0,
maintenance of blood-brain barrier,GO:0035633,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
maintenance of cell number,GO:0098727,Extensively Drug-Resistant Tuberculosis,MESH:D054908,1,Ethambutol,0,
maintenance of cell number,GO:0098727,Tuberculosis,MESH:D014376,2,"Ethambutol|isoniazid, pyrazinamide, rifampin drug combination",0,
maintenance of cell number,GO:0098727,"Tuberculosis, Central Nervous System",MESH:D020306,1,Ethambutol,0,
maintenance of cell number,GO:0098727,"Tuberculosis, Lymph Node",MESH:D014388,2,"Ethambutol|isoniazid, pyrazinamide, rifampin drug combination",0,
maintenance of cell number,GO:0098727,"Tuberculosis, Miliary",MESH:D014391,2,"Ethambutol|isoniazid, pyrazinamide, rifampin drug combination",0,
maintenance of cell number,GO:0098727,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Ethambutol,0,
maintenance of cell number,GO:0098727,"Tuberculosis, Osteoarticular",MESH:D014394,2,"Ethambutol|isoniazid, pyrazinamide, rifampin drug combination",0,
maintenance of cell number,GO:0098727,"Tuberculosis, Pleural",MESH:D014396,1,Ethambutol,0,
maintenance of cell number,GO:0098727,"Tuberculosis, Pulmonary",MESH:D014397,2,"Ethambutol|isoniazid, pyrazinamide, rifampin drug combination",0,
maintenance of cell number,GO:0098727,"Tuberculosis, Spinal",MESH:D014399,1,Ethambutol,0,
maintenance of location,GO:0051235,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
maintenance of location,GO:0051235,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
maintenance of protein location in cell,GO:0032507,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
maintenance of protein location in plasma membrane,GO:0072660,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
mammary gland involution,GO:0060056,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
mammary gland involution,GO:0060056,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CCL2
manganese ion transmembrane transport,GO:0071421,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,SLC11A1
manganese ion transmembrane transport,GO:0071421,Tuberculosis,MESH:D014376,1,Iron,1,SLC11A1
manganese ion transport,GO:0006828,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,SLC11A1
manganese ion transport,GO:0006828,Tuberculosis,MESH:D014376,0,,1,SLC11A1
MAPK cascade,GO:0000165,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,SLC11A1
MAPK cascade,GO:0000165,Tuberculosis,MESH:D014376,1,Tretinoin,1,SLC11A1
mast cell degranulation,GO:0043303,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Air Pollutants,0,
mast cell degranulation,GO:0043303,"Tuberculosis, Pulmonary",MESH:D014397,1,Air Pollutants,0,
maternal behavior,GO:0042711,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
maternal behavior,GO:0042711,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
maternal process involved in female pregnancy,GO:0060135,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
maternal process involved in female pregnancy,GO:0060135,"Tuberculosis, Pulmonary",MESH:D014397,0,,2,CCL2|MMP7
maternal process involved in parturition,GO:0060137,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,CCL2
maternal process involved in parturition,GO:0060137,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,CCL2
matrix metallopeptidase secretion,GO:1990773,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
megakaryocyte development,GO:0035855,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
megakaryocyte differentiation,GO:0030219,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
meiotic cell cycle,GO:0051321,Tuberculosis,MESH:D014376,1,Tretinoin,0,
meiotic cell cycle process involved in oocyte maturation,GO:1903537,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
meiotic cell cycle process involved in oocyte maturation,GO:1903537,Tuberculosis,MESH:D014376,1,Isoniazid,0,
meiotic cell cycle process involved in oocyte maturation,GO:1903537,"Tuberculosis, Central Nervous System",MESH:D020306,1,Isoniazid,0,
meiotic cell cycle process involved in oocyte maturation,GO:1903537,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Isoniazid,0,
meiotic cell cycle process involved in oocyte maturation,GO:1903537,"Tuberculosis, Lymph Node",MESH:D014388,1,Isoniazid,0,
meiotic cell cycle process involved in oocyte maturation,GO:1903537,"Tuberculosis, Meningeal",MESH:D014390,1,Isoniazid,0,
meiotic cell cycle process involved in oocyte maturation,GO:1903537,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Isoniazid,0,
meiotic cell cycle process involved in oocyte maturation,GO:1903537,"Tuberculosis, Pleural",MESH:D014396,1,Isoniazid,0,
meiotic cell cycle process involved in oocyte maturation,GO:1903537,"Tuberculosis, Pulmonary",MESH:D014397,1,Isoniazid,0,
meiotic cell cycle process involved in oocyte maturation,GO:1903537,"Tuberculosis, Spinal",MESH:D014399,1,Isoniazid,0,
meiotic spindle organization,GO:0000212,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
meiotic spindle organization,GO:0000212,Tuberculosis,MESH:D014376,1,Isoniazid,0,
meiotic spindle organization,GO:0000212,"Tuberculosis, Central Nervous System",MESH:D020306,1,Isoniazid,0,
meiotic spindle organization,GO:0000212,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Isoniazid,0,
meiotic spindle organization,GO:0000212,"Tuberculosis, Lymph Node",MESH:D014388,1,Isoniazid,0,
meiotic spindle organization,GO:0000212,"Tuberculosis, Meningeal",MESH:D014390,1,Isoniazid,0,
meiotic spindle organization,GO:0000212,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Isoniazid,0,
meiotic spindle organization,GO:0000212,"Tuberculosis, Pleural",MESH:D014396,1,Isoniazid,0,
meiotic spindle organization,GO:0000212,"Tuberculosis, Pulmonary",MESH:D014397,1,Isoniazid,0,
meiotic spindle organization,GO:0000212,"Tuberculosis, Spinal",MESH:D014399,1,Isoniazid,0,
melanin biosynthetic process,GO:0042438,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
melanin biosynthetic process,GO:0042438,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
melanosome localization,GO:0032400,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
membrane depolarization,GO:0051899,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
membrane depolarization,GO:0051899,"Tuberculosis, Pulmonary",MESH:D014397,2,Arsenic|Particulate Matter,0,
membrane disassembly,GO:0030397,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
membrane disassembly,GO:0030397,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
membrane lipid catabolic process,GO:0046466,Latent Tuberculosis,MESH:D055985,1,Isoniazid,0,
membrane lipid catabolic process,GO:0046466,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
membrane lipid catabolic process,GO:0046466,Tuberculosis,MESH:D014376,8,Ciprofloxacin|Gentamicins|Iron|Isoniazid|Kanamycin|Rifampin|Tretinoin|Verapamil,0,
membrane lipid catabolic process,GO:0046466,"Tuberculosis, Central Nervous System",MESH:D020306,2,Isoniazid|Rifampin,0,
membrane lipid catabolic process,GO:0046466,"Tuberculosis, Gastrointestinal",MESH:D014385,2,Isoniazid|Rifampin,0,
membrane lipid catabolic process,GO:0046466,"Tuberculosis, Lymph Node",MESH:D014388,2,Isoniazid|Rifampin,0,
membrane lipid catabolic process,GO:0046466,"Tuberculosis, Meningeal",MESH:D014390,2,Isoniazid|Rifampin,0,
membrane lipid catabolic process,GO:0046466,"Tuberculosis, Multidrug-Resistant",MESH:D018088,3,Isoniazid|Kanamycin|Rifampin,0,
membrane lipid catabolic process,GO:0046466,"Tuberculosis, Pleural",MESH:D014396,2,Isoniazid|Rifampin,0,
membrane lipid catabolic process,GO:0046466,"Tuberculosis, Pulmonary",MESH:D014397,8,Air Pollutants|Arsenic|Carbon Monoxide|Isoniazid|Nitrogen Dioxide|Particulate Matter|Rifabutin|Rifampin,0,
membrane lipid catabolic process,GO:0046466,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
membrane lipid catabolic process,GO:0046466,"Tuberculosis, Spinal",MESH:D014399,3,Ciprofloxacin|Isoniazid|Rifampin,0,
membrane organization,GO:0061024,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
membrane organization,GO:0061024,Tuberculosis,MESH:D014376,2,Pyrazinamide|Rifampin,0,
membrane organization,GO:0061024,"Tuberculosis, Central Nervous System",MESH:D020306,2,Pyrazinamide|Rifampin,0,
membrane organization,GO:0061024,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Rifampin,0,
membrane organization,GO:0061024,"Tuberculosis, Lymph Node",MESH:D014388,2,Pyrazinamide|Rifampin,0,
membrane organization,GO:0061024,"Tuberculosis, Meningeal",MESH:D014390,2,Pyrazinamide|Rifampin,0,
membrane organization,GO:0061024,"Tuberculosis, Multidrug-Resistant",MESH:D018088,2,Pyrazinamide|Rifampin,0,
membrane organization,GO:0061024,"Tuberculosis, Pleural",MESH:D014396,1,Rifampin,0,
membrane organization,GO:0061024,"Tuberculosis, Pulmonary",MESH:D014397,3,Particulate Matter|Pyrazinamide|Rifampin,0,
membrane organization,GO:0061024,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
membrane organization,GO:0061024,"Tuberculosis, Spinal",MESH:D014399,2,Pyrazinamide|Rifampin,0,
membrane protein ectodomain proteolysis,GO:0006509,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,MMP7
membrane protein intracellular domain proteolysis,GO:0031293,"Tuberculosis, Pulmonary",MESH:D014397,0,,1,MMP7
membrane repolarization,GO:0086009,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Gatifloxacin,0,
memory,GO:0007613,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
memory,GO:0007613,Tuberculosis,MESH:D014376,2,Aminosalicylic Acid|Tretinoin,0,
memory,GO:0007613,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Aminosalicylic Acid,0,
memory,GO:0007613,"Tuberculosis, Pulmonary",MESH:D014397,3,Air Pollutants|Arsenic|Particulate Matter,0,
memory T cell proliferation,GO:0061485,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
memory T cell proliferation,GO:0061485,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
menarche,GO:0042696,"Tuberculosis, Pulmonary",MESH:D014397,1,Arsenic,0,
metabolic process,GO:0008152,Latent Tuberculosis,MESH:D055985,1,Pyridoxine,0,
metabolic process,GO:0008152,Tuberculosis,MESH:D014376,3,Chenodeoxycholic Acid|Gentamicins|Pyridoxine,0,
metabolic process,GO:0008152,"Tuberculosis, Pulmonary",MESH:D014397,2,Arsenic|Pyridoxine,0,
metal ion homeostasis,GO:0055065,Tuberculosis,MESH:D014376,1,Iron,0,
metal ion transport,GO:0030001,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,SLC11A1
metal ion transport,GO:0030001,Tuberculosis,MESH:D014376,0,,1,SLC11A1
methionine metabolic process,GO:0006555,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
methionine metabolic process,GO:0006555,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
methotrexate transport,GO:0051958,Tuberculosis,MESH:D014376,1,Verapamil,0,
methylation,GO:0032259,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
methylation,GO:0032259,"Tuberculosis, Pulmonary",MESH:D014397,2,Arsenic|Particulate Matter,0,
MHC class II biosynthetic process,GO:0045342,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,SLC11A1
MHC class II biosynthetic process,GO:0045342,Tuberculosis,MESH:D014376,0,,1,SLC11A1
MHC class II biosynthetic process,GO:0045342,"Tuberculosis, Bovine",MESH:D014380,0,,1,IL4
microglia development,GO:0014005,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,1,TLR2
microglia development,GO:0014005,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
microglia development,GO:0014005,"Tuberculosis, Pulmonary",MESH:D014397,2,Arsenic|Particulate Matter,0,
microglial cell activation,GO:0001774,"MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",OMIM:607948,0,,3,IFNG|IFNGR1|TLR2
microglial cell activation,GO:0001774,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
microglial cell activation,GO:0001774,"Tuberculosis, Bovine",MESH:D014380,0,,1,IL4
microglial cell activation,GO:0001774,"Tuberculosis, Pulmonary",MESH:D014397,4,Air Pollutants|Arsenic|Carbon Monoxide|Particulate Matter,0,
microglial cell migration,GO:1904124,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
microglial cell migration,GO:1904124,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
microglial cell proliferation,GO:0061518,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
microglial cell proliferation,GO:0061518,"Tuberculosis, Pulmonary",MESH:D014397,3,Air Pollutants|Arsenic|Particulate Matter,0,
micronucleus organization,GO:0032125,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
micronucleus organization,GO:0032125,Tuberculosis,MESH:D014376,2,Rifampin|Verapamil,0,
micronucleus organization,GO:0032125,"Tuberculosis, Central Nervous System",MESH:D020306,1,Rifampin,0,
micronucleus organization,GO:0032125,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Rifampin,0,
micronucleus organization,GO:0032125,"Tuberculosis, Lymph Node",MESH:D014388,1,Rifampin,0,
micronucleus organization,GO:0032125,"Tuberculosis, Meningeal",MESH:D014390,1,Rifampin,0,
micronucleus organization,GO:0032125,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Rifampin,0,
micronucleus organization,GO:0032125,"Tuberculosis, Pleural",MESH:D014396,1,Rifampin,0,
micronucleus organization,GO:0032125,"Tuberculosis, Pulmonary",MESH:D014397,4,Air Pollutants|Arsenic|Particulate Matter|Rifampin,0,
micronucleus organization,GO:0032125,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
micronucleus organization,GO:0032125,"Tuberculosis, Spinal",MESH:D014399,1,Rifampin,0,
microtubule cytoskeleton organization,GO:0000226,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
microtubule cytoskeleton organization,GO:0000226,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
microvillus organization,GO:0032528,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
microvillus organization,GO:0032528,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
miRNA transcription,GO:0061614,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
miRNA transcription,GO:0061614,"Tuberculosis, Pulmonary",MESH:D014397,2,Air Pollutants|Particulate Matter,0,
miRNA transport,GO:1990428,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
miRNA transport,GO:1990428,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
mitochondrial ATP synthesis coupled electron transport,GO:0042775,Extensively Drug-Resistant Tuberculosis,MESH:D054908,2,entacapone|Tolcapone,0,
mitochondrial ATP synthesis coupled electron transport,GO:0042775,"Tuberculosis, Multidrug-Resistant",MESH:D018088,2,entacapone|Tolcapone,0,
mitochondrial cytochrome c oxidase assembly,GO:0033617,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
mitochondrial cytochrome c oxidase assembly,GO:0033617,"Tuberculosis, Pulmonary",MESH:D014397,1,Particulate Matter,0,
mitochondrial depolarization,GO:0051882,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,1,Particulate Matter,0,
mitochondrial depolarization,GO:0051882,Tuberculosis,MESH:D014376,2,Iron|Rifampin,0,
mitochondrial depolarization,GO:0051882,"Tuberculosis, Central Nervous System",MESH:D020306,1,Rifampin,0,
mitochondrial depolarization,GO:0051882,"Tuberculosis, Gastrointestinal",MESH:D014385,1,Rifampin,0,
mitochondrial depolarization,GO:0051882,"Tuberculosis, Lymph Node",MESH:D014388,1,Rifampin,0,
mitochondrial depolarization,GO:0051882,"Tuberculosis, Meningeal",MESH:D014390,1,Rifampin,0,
mitochondrial depolarization,GO:0051882,"Tuberculosis, Multidrug-Resistant",MESH:D018088,1,Rifampin,0,
mitochondrial depolarization,GO:0051882,"Tuberculosis, Pleural",MESH:D014396,1,Rifampin,0,
mitochondrial depolarization,GO:0051882,"Tuberculosis, Pulmonary",MESH:D014397,3,Arsenic|Particulate Matter|Rifampin,0,
mitochondrial depolarization,GO:0051882,"Tuberculosis, Renal",MESH:D014398,1,Rifampin,0,
mitochondrial depolarization,GO:0051882,"Tuberculosis, Spinal",MESH:D014399,1,Rifampin,0,
mitochondrial DNA metabolic process,GO:0032042,"Mycobacterium tuberculosis, susceptibility to infection by",MESH:C536092,2,Air Pollutants|Particulate Matter,0,
mitochondrial DNA metabolic process,GO:0032042,Tuberculosis,MESH:D014376,1,Triazoles,0,
mitochondrial DNA metabolic process,GO:0032042,"Tuberculosis, Pulmonary",MESH:D014397,4,Air Pollutants|Arsenic|Nitrogen Dioxide|Particulate Matter,0,
"mitochondrial electron transport, cytochrome c to oxygen",GO:0006123,Extensively Drug-Resistant Tuberculosis,MESH:D054908,2,entacapone|Tolcapone,0,
